Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in J Alzheimers Dis

Retrieve available abstracts of 860 articles:
HTML format
Text format



Single Articles


    June 2016
  1. MAKOVAC E, Serra L, Spano B, Giulietti G, et al
    Different Patterns of Correlation between Grey and White Matter Integrity Account for Behavioral and Psychological Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:591-604.
    PubMed     Text format     Abstract available


    April 2016
  2. HENSLEY K, Kursula P
    Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  3. BERGER M, Nadler JW, Friedman A, McDonagh DL, et al
    The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  4. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:1291-5.
    PubMed     Text format    


  5. OTA K, Oishi N, Ito K, Fukuyama H, et al
    Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  6. ZHAI Y, Yamashita T, Nakano Y, Sun Z, et al
    Disruption of White Matter Integrity by Chronic Cerebral Hypoperfusion in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  7. HOSCHEIDT SM, Starks EJ, Oh JM, Zetterberg H, et al
    Insulin Resistance is Associated with Increased Alzheimer's Disease Pathology and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  8. CONDE-SALA JL, Turro-Garriga O, Portellano-Ortiz C, Vinas-Diez V, et al
    Self-Perceived Quality of Life Among Patients with Alzheimer's Disease: Two Longitudinal Models of Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  9. WANG W, Lu L, Wu QQ, Jia JP, et al
    Brain Amyloid-beta Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  10. REGO A, Viana SD, Ribeiro CA, Rodrigues-Santos P, et al
    Monophosphoryl Lipid-A: A Promising Tool for Alzheimer's Disease Toll.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  11. XING Y, Tang Y, Zhao L, Wang Q, et al
    Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  12. NILSSON ED, Melander O, Elmstahl S, Lethagen E, et al
    Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  13. TEIPEL S, Grothe MJ
    Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  14. HENNEGES C, Reed C, Chen YF, Dell'Agnello G, et al
    Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  15. WARAGAI M, Adame A, Trinh I, Sekiyama K, et al
    Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  16. ZHAN Y, Ma J, Alexander-Bloch AF, Xu K, et al
    Longitudinal Study of Impaired Intra- and Inter-Network Brain Connectivity in Subjects at High Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  17. BEHESHTI I, Olya HG, Demirel H
    Risk Assessment of Alzheimer's Disease using the Information Diffusion Model from Structural Magnetic Resonance Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  18. HUANG HC, Zheng BW, Guo Y, Zhao J, et al
    Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  19. JAYNE T, Newman M, Verdile G, Sutherland G, et al
    Evidence for and Against a Pathogenic Role of Reduced gamma-Secretase Activity in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  20. ZHAI Y, Yin S, Zhang D
    Association between Antipsychotic Drugs and Mortality in Older Persons with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  21. EBRAHIMIE E, Moussavi-Nik SH, Newman M, Van Der Hoek M, et al
    The Zebrafish Equivalent of Alzheimer's Disease-Associated PRESENILIN Isoform PS2V Regulates Inflammatory and Other Responses to Hypoxic Stress.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  22. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:929-934.
    PubMed     Text format    


  23. PIAZZA F, Winblad B
    Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  24. VIDAL JS, Hanon O, Funalot B, Brunel N, et al
    Low Serum Insulin-Like Growth Factor-I Predicts Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  25. KUSTER OC, Kosel J, Spohn S, Schurig N, et al
    Cognitive Reserve in Alzheimer's Dementia: Diagnostic Accuracy of a Testing-the-Limits Paradigm.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  26. CUCHILLO-IBANEZ I, Balmaceda V, Mata-Balaguer T, Lopez-Font I, et al
    Reelin in Alzheimer's Disease, Increased Levels but Impaired Signaling: When More is Less.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  27. HIRNI DI, Kivisaari SL, Krumm S, Monsch AU, et al
    Neuropsychological Markers of Medial Perirhinal and Entorhinal Cortex Functioning are Impaired Twelve Years Preceding Diagnosis of Alzheimer's Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  28. CLEMENTS-CORTES A, Ahonen H, Evans M, Freedman M, et al
    Short-Term Effects of Rhythmic Sensory Stimulation in Alzheimer's Disease: An Exploratory Pilot Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  29. YANG C, Huang X, Huang X, Mai H, et al
    Aquaporin-4 and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  30. HU Q, Teng W, Li J, Hao F, et al
    Homocysteine and Alzheimer's Disease: Evidence for a Causal Link from Mendelian Randomization.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  31. MIN JY, Min KB
    The Folate-Vitamin B12 Interaction, Low Hemoglobin, and the Mortality Risk from Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  32. ZHAO QF, Wan Y, Wang HF, Sun FR, et al
    ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-beta Pathology.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  33. EL HAJ M, Kapogiannis D, Antoine P
    Phenomenological Reliving and Visual Imagery During Autobiographical Recall in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  34. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:631-5.
    PubMed     Text format    


  35. NHO K, Saykin AJ, Nelson PT
    Hippocampal Sclerosis of Aging, a Common Alzheimer's Disease 'Mimic': Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  36. SCHUTT T, Helboe L, Ostergaard Pedersen L, Waldemar G, et al
    Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  37. WANG HF, Wan Y, Hao XK, Cao L, et al
    Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  38. HOMMA A, Atarashi H, Kubota N, Nakai K, et al
    Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  39. ITZHAKI RF, Lathe R, Balin BJ, Ball MJ, et al
    Microbes and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format    


  40. YE Q, Bai F, Zhang Z
    Shared Genetic Risk Factors for Late-Life Depression and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  41. SPILMAN PR, Corset V, Gorostiza O, Poksay KS, et al
    Netrin-1 Interrupts Amyloid-beta Amplification, Increases sAbetaPPalpha in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  42. SHANG J, Yamashita T, Zhai Y, Nakano Y, et al
    Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer's Disease Model Mouse.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  43. LOPEZ ME, Turrero A, Cuesta P, Lopez-Sanz D, et al
    Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  44. JAHNG GH, Oh J, Lee DW, Kim HG, et al
    Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  45. FEMMINELLA GD, Ninan S, Atkinson R, Fan Z, et al
    Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?
    J Alzheimers Dis. 2016;51:1275-89.
    PubMed     Text format     Abstract available


  46. YOON B, Yang DW, Hong YJ, Choi SH, et al
    Differences in Depressive Patterns According to Disease Severityin Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  47. TIIHONEN M, Taipale H, Tanskanen A, Tiihonen J, et al
    Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  48. PASQUIER F, Sadowsky C, Holstein A, Leterme GL, et al
    Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    February 2016
  49. REMINGTON R, Bechtel C, Larsen D, Samar A, et al
    Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  50. FLORIAN H, Meier A, Gauthier S, Lipschitz S, et al
    Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  51. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:327-331.
    PubMed     Text format    


  52. PECK K, Girard TA, Russo F, Fiocco AJ, et al
    Music and Memory in Alzheimer's Disease and The Potential Underlying Mechanisms.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  53. SCHILLING MA
    Unraveling Alzheimer's: Making Sense of the Relationship between Diabetes and Alzheimer's Disease1.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  54. TAN CC, Wan Y, Tan MS, Zhang W, et al
    Association of Frontotemporal Dementia GWAS Loci with Late-Onset Alzheimer's Disease in a Northern Han Chinese Population.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  55. LAVALLEE MM, Gandini D, Rouleau I, Vallet GT, et al
    A Qualitative Impairment in Face Perception in Alzheimer's Disease: Evidence from a Reduced Face Inversion Effect.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  56. GOMAR JJ, Conejero-Goldberg C, Davies P, Goldberg TE, et al
    Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  57. MASOUD AM, Bihaqi SW, Machan JT, Zawia NH, et al
    Early-Life Exposure to Lead (Pb) Alters the Expression of microRNA that Target Proteins Associated with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  58. WONG S, Bertoux M, Savage G, Hodges JR, et al
    Comparison of Prefrontal Atrophy and Episodic Memory Performance in Dysexecutive Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  59. MONTESANTO A, Crocco P, Anfossi M, Smirne N, et al
    The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer's Disease and Modifies the Disease's Risk in APOE-varepsilon4 Carriers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  60. GUILLOT F, Kemppainen S, Lavasseur G, Miettinen PO, et al
    Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AbetaPP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  61. ONGALI B, Nicolakakis N, Tong XK, Aboulkassim T, et al
    Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  62. BOUSIGES O, Cretin B, Lavaux T, Philippi N, et al
    Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Abeta42, and Abeta40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  63. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:1257-61.
    PubMed     Text format    


  64. SAKAI K, Senda T, Hata R, Kuroda M, et al
    Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  65. BARTHELEMY NR, Gabelle A, Hirtz C, Fenaille F, et al
    Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  66. CHAI YL, Yeo HK, Wang J, Hilal S, et al
    Apolipoprotein varepsilon4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  67. SANCHEZ-VALLE R, Monte GC, Sala-Llonch R, Bosch B, et al
    White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  68. SUPPA P, Hampel H, Kepp T, Lange C, et al
    Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  69. SINGHRAO SK, Harding A, Chukkapalli S, Olsen I, et al
    Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  70. PLUTA R, Kocki J, Ulamek-Koziol M, Petniak A, et al
    Discrepancy in Expression of beta-Secretase and Amyloid-beta Protein Precursor in Alzheimer-Related Genes in the Rat Medial Temporal Lobe Cortex Following Transient Global Brain Ischemia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  71. CHAU SA, Chung J, Herrmann N, Eizenman M, et al
    Apathy and Attentional Biases in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  72. LYOO CH, Cho H, Choi JY, Hwang MS, et al
    Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  73. LOU G, Zhang Q, Xiao F, Xiang Q, et al
    Intranasal TAT-haFGF Improves Cognition and Amyloid-beta Pathology in an AbetaPP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  74. SOUTHAM KA, Vincent AJ, Small DH
    Do Microglia Default on Network Maintenance in Alzheimer's Disease?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  75. DINGOVA D, Fazekas T, Okuliarova P, Strbova J, et al
    Low Plasma Cholinesterase Activities are associated with Deficits in Spatial Orientation, Reduced Ability to Perform Basic Activities of Daily Living, and Low Body Mass Index in Patients with Progressed Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  76. MOON Y, Han SH, Moon WJ
    Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  77. BONET-COSTA V, Herranz-Perez V, Blanco-Gandia M, Mas-Bargues C, et al
    Clearing Amyloid-beta through PPARgamma/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  78. GODEFROY O, Bakchine S, Verny M, Delabrousse-Mayoux JP, et al
    Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  79. FANG D, Zhang Z, Li H, Yu Q, et al
    Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer's disease Mouse Brain.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  80. HESSMANN P, Seeberg G, Reese JP, Dams J, et al
    Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  81. SCHUBERT S, Leyton CE, Hodges JR, Piguet O, et al
    Longitudinal Memory Profiles in Behavioral-Variant Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  82. GRANGER MW, Franko B, Taylor MW, Messier C, et al
    A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  83. ALLISON SL, Fagan AM, Morris JC, Head D, et al
    Spatial Navigation in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  84. CHEN HY, Panegyres PK
    The Role of Ethnicity in Alzheimer's Disease: Findings From The C-PATH Online Data Repository.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  85. WHITE MT, Shaw LM, Xie SX
    Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  86. SERRA L, Cercignani M, Mastropasqua C, Torso M, et al
    Longitudinal Changes in Functional Brain Connectivity Predicts Conversionto Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  87. ASO E, Andres-Benito P, Carmona M, Maldonado R, et al
    Cannabinoid Receptor 2 Participates in Amyloid-beta Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  88. D'ONOFRIO G, Panza F, Sancarlo D, Paris FF, et al
    Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  89. LOUWERSHEIMER E, Keulen MA, Steenwijk MD, Wattjes MP, et al
    Heterogeneous Language Profiles in Patients with Primary Progressive Aphasiadue to Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  90. LI WX, Dai SX, Liu JQ, Wang Q, et al
    Integrated Analysis of Alzheimer's Disease and Schizophrenia Dataset Revealed Different Expression Pattern in Learningand Memory.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  91. WRUCK W, Schroter F, Adjaye J
    Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsiesand iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Revealsan Association with FOXA1 and FOXA2 Gene Regulatory Networks.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  92. KIDA J, Nemoto K, Ikejima C, Bun S, et al
    Impact of Depressive Symptomson Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  93. LACALLE-AURIOLES M, Javier Navas-Sanchez F, Aleman-Gomez Y, Olazaran J, et al
    The Disconnection Hypothesis in Alzheimer's Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural, Perfusion, and Diffusion Tensor Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  94. DUGGER BN, Whiteside CM, Maarouf CL, Walker DG, et al
    The Presence of Select Tau Speciesin Human Peripheral Tissues and Their Relation to Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  95. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:907-911.
    PubMed     Text format    


    January 2016
  96. BOCCHETTA M, Mega A, Bernardi L, Di Maria E, et al
    Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  97. EUSTACHE P, Nemmi F, Saint-Aubert L, Pariente J, et al
    Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  98. TONG M, Deochand C, Didsbury J, de la Monte SM, et al
    T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  99. MELAH KE, Lu SY, Hoscheidt SM, Alexander AL, et al
    Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  100. LANGLOIS R, Joubert S, Benoit S, Dostie V, et al
    Memory for Public Events in Mild Cognitive Impairment and Alzheimer's Disease:The Importance of Rehearsal.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  101. ROBILLARD JM
    The Online Environment: A Key Variable in the Ethical Response to Complementary and Alternative Medicine for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  102. DODICH A, Cerami C, Crespi C, Canessa N, et al
    Differential Impairment of Cognitive and Affective Mentalizing Abilities in Neurodegenerative Dementias: Evidence from Behavioral Variant of Frontotemporal Dementia, Alzheimer's Disease, and Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  103. RACINE E, Forlini C, Aspler J, Chandler J, et al
    Complementary and Alternative Medicine in the Context of Earlier Diagnoses of Alzheimer's Disease: Opening the Conversation to Prepare Ethical Responses.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  104. TURRO-GARRIGA O, Garre-Olmo J, Calvo-Perxas L, Rene-Ramirez R, et al
    Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  105. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:617-21.
    PubMed     Text format    


  106. MANOUSOPOULOU A, Saito S, Yamamoto Y, Al-Daghri NM, et al
    Hemisphere Asymmetry of Response to Pharmacologic Treatment in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  107. SMITH R, Wibom M, Olsson T, Hagerstrom D, et al
    Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  108. NAGATA T, Shinagawa S, Nakajima S, Plitman E, et al
    Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  109. WANG HF, Tan L, Cao L, Zhu XC, et al
    Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  110. PASQUINI L, Scherr M, Tahmasian M, Myers NE, et al
    Increased Intrinsic Activity of Medial-Temporal Lobe Subregions is Associated with Decreased Cortical Thickness of Medial-Parietal Areas in Patients with Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  111. GALLUCCI M, Spagnolo P, Arico M, Grossi E, et al
    Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  112. RODRIGUEZ-PERDIGON M, Solas M, Javier Ramirez M
    JNK: A Putative Link Between Insulin Signaling and VGLUT1 in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  113. ZHANG Y, Wang S, Phillips P, Yang J, et al
    Three-Dimensional Eigenbrain for the Detection of Subjects and Brain Regions Related with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  114. MORIN JP, Ceron-Solano G, Velazquez-Campos G, Pacheco-Lopez G, et al
    Spatial Memory Impairment is Associated with Intraneural Amyloid-beta Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  115. NUNEZ K, Kay J, Krotow A, Tong M, et al
    Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  116. MANSO Y, Comes G, Lopez-Ramos JC, Belfiore M, et al
    Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  117. NIEMANTSVERDRIET E, Goossens J, Struyfs H, Martin JJ, et al
    Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  118. WANG J, Tan L, Yu JT
    Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  119. BABIC LEKO M, Borovecki F, Dejanovic N, Hof PR, et al
    Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  120. SIOTTO M, Simonelli I, Pasqualetti P, Mariani S, et al
    Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  121. BOCCARDI V, Ruggiero C, Patriti A, Marano L, et al
    Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  122. WANG HL, Wang YY, Liu XG, Kuo SH, et al
    Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  123. FERNANDEZ G, Manes F, Politi LE, Orozco D, et al
    Patients with Mild Alzheimer's Disease Fail When Using Their Working Memory: Evidence from the Eye Tracking Technique.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  124. QIU H, Zhong R, Liu H, Zhang F, et al
    Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AbetaPPswe/PS1DeltaE9 Mice.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  125. MAES A, Anthonissen R, Wambacq S, Simons K, et al
    The Cytome Assay as a Tool to Investigate the Possible Association Between Exposure to Extremely Low Frequency Magnetic Fields and an Increased Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  126. KIM HJ, Cha J, Lee JM, Shin JS, et al
    Distinctive Resting State Network Disruptions Among Alzheimer's Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  127. KOCH G, Di Lorenzo F, Del Olmo MF, Bonni S, et al
    Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  128. ROHER AE, Maarouf CL, Kokjohn TA
    Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  129. VIJAYARAGHAVAN S, Darreh-Shori T, Rongve A, Berge G, et al
    Association of Butyrylcholinesterase-K Allele and Apolipoprotein E varepsilon4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  130. HUANG F, Shang Y, Luo Y, Wu P, et al
    Lower Prevalence of Alzheimer's Disease among Tibetans: Association with Religious and Genetic Factors.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  131. RENARD D, Wacongne A, Ayrignac X, Charif M, et al
    Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  132. DZIEDZIC T, Pera J, Klimkowicz-Mrowiec A, Mroczko B, et al
    Biochemical and Radiological Markers of Alzheimer's Disease Progression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  133. IBARRIA M, Alegret M, Valero S, Morera A, et al
    Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  134. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:297-300.
    PubMed     Text format    


    December 2015

  135. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:1193-6.
    PubMed     Text format    



  136. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:889-92.
    PubMed     Text format    


  137. LEWCZUK P, Kornhuber J, Toledo JB, Trojanowski JQ, et al
    Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia Subjects.
    J Alzheimers Dis. 2015;49:887.
    PubMed     Text format    


  138. BENNETT J, Burns J, Welch P, Bothwell R, et al
    Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  139. DERMODY N, Hornberger M, Piguet O, Hodges JR, et al
    Prospective Memory Impairments in Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia: Clinical and Neural Correlates.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  140. HOFFMANN K, Sobol NA, Frederiksen KS, Beyer N, et al
    Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  141. YAMASHITA S, Kiko T, Fujiwara H, Hashimoto M, et al
    Alterations in the Levels of Amyloid-beta, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer's Disease: Possible Interactions between Amyloid-beta and These Lipids.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  142. CHAKRABARTI M, McDonald AJ, Will Reed J, Moss MA, et al
    Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  143. WANG S, Zhang Y, Liu G, Phillips P, et al
    Detection of Alzheimer's Disease by Three-Dimensional Displacement Field Estimation in Structural Magnetic Resonance Imaging.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  144. GARDENER SL, Rainey-Smith SR, Martins RN
    Diet and Inflammation in Alzheimer's Disease and Related Chronic Diseases: A Review.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  145. EZRA A, Rabinovich-Nikitin I, Rabinovich-Toidman P, Solomon B, et al
    Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  146. BARTOLOTTI N, Segura L, Lazarov O
    Diminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer's Disease Mice.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


    November 2015
  147. MALISHKEVICH A, Marshall GA, Schultz AP, Sperling RA, et al
    Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  148. WEISSMANN R, Huttenrauch M, Kacprowski T, Bouter Y, et al
    Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  149. STOCKBURGER C, Miano D, Baeumlisberger M, Pallas T, et al
    A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  150. CHANG YL, Yen YS, Chen TF, Yan SH, et al
    Clinical Dementia Rating Scale Detects White Matter Changes in Older Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  151. QUINTANA-HERNANDEZ DJ, Miro-Barrachina MT, Ibanez-Fernandez IJ, Pino AS, et al
    Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  152. FISCHER CE, Qian W, Schweizer TA, Millikin CP, et al
    Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  153. STEENLAND K, Goldstein FC, Levey A, Wharton W, et al
    A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and Caucasians.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  154. GAO L, Cui Z, Shen L, Ji HF, et al
    Shared Genetic Etiology between Type 2 Diabetes and Alzheimer's Disease Identified by Bioinformatics Analysis.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  155. AVONDINO E, Antoine P
    Heterogeneity of Cognitive Anosognosia and its Variation with the Severity of Dementia in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  156. MARRA C, Gainotti G, Fadda L, Perri R, et al
    Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  157. SANTOS CY, Lim YY, Wu WC, Machan JT, et al
    Resting-State Cardiac Workload is Related to Both Increased Neocortical Aggregation of Amyloid-beta and Relative Impairments in Spatial Working Memory in Pre-Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  158. GABELLE A, Gutierrez LA, Dartigues JF, Ritchie K, et al
    Palmomental Reflex a Relevant Sign in Early Alzheimer's Disease Diagnosis?
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  159. NOVAK G, Fox N, Clegg S, Nielsen C, et al
    Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  160. LIU J, Zhang X, Yu C, Duan Y, et al
    Impaired Parahippocampus Connectivity in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  161. DUKART J, Sambataro F, Bertolino A
    Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  162. SATTLECKER M, Khondoker M, Proitsi P, Williams S, et al
    Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  163. TOSTO G, Monsell SE, Hawes SE, Giuseppe B, et al
    Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  164. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:583-7.
    PubMed     Text format    


  165. BERTOUX M, de Souza Lc LC, O'Callaghan C, Greve A, et al
    Social Cognition Deficits: The Key to Discriminate Behavioral Variant Frontotemporal Dementia from Alzheimer's Disease Regardless of Amnesia?
    J Alzheimers Dis. 2015;49:1065-74.
    PubMed     Text format     Abstract available


  166. RHODIUS-MEESTER HF, Koikkalainen J, Mattila J, Teunissen CE, et al
    Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  167. LANGE C, Suppa P, Frings L, Brenner W, et al
    Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  168. STOGMANN E, Moser D, Klug S, Gleiss A, et al
    Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  169. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:267-70.
    PubMed     Text format    


    October 2015
  170. ROSENBERGER AF, Hilhorst R, Coart E, Garcia Barrado L, et al
    Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  171. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:1129-32.
    PubMed     Text format    


  172. DIAZ M, Fabelo N, Casanas-Sanchez V, Marin R, et al
    Hippocampal Lipid Homeostasis in APP/PS1 Mice is Modulated by a Complex Interplay Between Dietary DHA and Estrogens: Relevance for Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  173. JOHNEN A, Frommeyer J, Modes F, Wiendl H, et al
    Dementia Apraxia Test (DATE): A Brief Tool to Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer's Dementia based on Apraxia Profiles.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  174. BERGE G, Lauridsen C, Sando SB, Holder D, et al
    Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  175. WU HZ, Ong KL, Seeher K, J Armstrong N, et al
    Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  176. MADHAVAN A, Schwarz CG, Duffy JR, Strand EA, et al
    Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  177. DUBOIS B, Padovani A, Scheltens P, Rossi A, et al
    Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  178. SAARELAINEN L, Taipale H, Koponen M, Tanskanen A, et al
    The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  179. FA M, Zhang H, Staniszewski A, Saeed F, et al
    Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  180. BANERJEE P, Sahoo A, Anand S, Bir A, et al
    The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-beta Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  181. PINNOCK EC, Jovanovic K, Pinto MG, Ferreira E, et al
    LRP/LR Antibody Mediated Rescuing of Amyloid-beta-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  182. KOPPARA A, Wolfsgruber S, Kleineidam L, Schmidtke K, et al
    The Latent Dementia Phenotype delta is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  183. YE BS, Jang EY, Kim SY, Kim EJ, et al
    Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  184. FRASER KC, Meltzer JA, Rudzicz F
    Linguistic Features Identify Alzheimer's Disease in Narrative Speech.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  185. VOYLE N, Keohane A, Newhouse S, Lunnon K, et al
    A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  186. SHAH DJ, Rohlfing F, Anand S, Johnson WE, et al
    Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  187. GARCIA BARRADO L, Coart E, Vanderstichele HM, Burzykowski T, et al
    Transferring Cut-off Values between Assays for Cerebrospinal Fluid Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  188. PAN Y, Terpstra E, Wang Y, Qiao F, et al
    Dysregulation and Diagnostic Potential of microRNA in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  189. MINH DO T, Dodacki A, Alata W, Calon F, et al
    Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-beta Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  190. JOUSSAIN P, Bessy M, Fournel A, Ferdenzi C, et al
    Altered Affective Evaluations of Smells in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  191. LEVAULT KR, Tischkau SA, Brewer GJ
    Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  192. ARAB L, Sabbagh MN
    Are Certain Lifestyle Habits Associated with Lower Alzheimer's Disease Risk?
    J Alzheimers Dis. 2015;48:877.
    PubMed     Text format    



  193. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:871-4.
    PubMed     Text format    


  194. GUO Z, Liu X, Jia X, Hou H, et al
    Regional Coherence Changes in Alzheimer's Disease Patients with Depressive Symptoms: A Resting-State Functional MRI Study.
    J Alzheimers Dis. 2015;48:603-11.
    PubMed     Text format     Abstract available


    September 2015
  195. PASTOR P, Moreno F, Clarimon J, Ruiz A, et al
    MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEvarepsilon4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  196. COUTU JP, Goldblatt A, Rosas HD, Salat DH, et al
    White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  197. GAVETT BE, John SE, Gurnani AS, Bussell CA, et al
    The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  198. AGOSTINI S, Mancuso R, Baglio F, Cabinio M, et al
    Lack of Evidence for a Role of HHV-6 in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  199. PIERROT N, Lhommel R, Quenon L, Hanseeuw B, et al
    Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  200. CONEJERO-GOLDBERG C, Hyde TM, Chen S, Herman MM, et al
    Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer's Disease: Patterns of Protection and Degeneration.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  201. LIZIO R, Del Percio C, Marzano N, Soricelli A, et al
    Neurophysiological Assessment of Alzheimer's Disease Individuals by a Single Electroencephalographic Marker.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  202. VALECH N, Mollica MA, Olives J, Tort A, et al
    Informants' Perception of Subjective Cognitive Decline Helps to Discriminate Preclinical Alzheimer's Disease from Normal Aging.
    J Alzheimers Dis. 2015;48 Suppl 1:S87-98.
    PubMed     Text format     Abstract available


  203. WHITEHOUSE PJ, George DR
    A Tale of Two Reports: What Recent Publications from the Alzheimer's Association and Institute of Medicine say about the State of the Field.
    J Alzheimers Dis. 2015.
    PubMed     Text format    


  204. SUN X, Ma R, Yao X, Shang X, et al
    Concanavalin Agglutinin Levels are Decreased in Peripheral Blood of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  205. YOON B, Shim YS, Park HK, Park S, et al
    Predictive Factors for Disease Progression in Patients With Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  206. SAVASTANO A, Klafki H, Haussmann U, Oberstein TJ, et al
    N-Truncated Abeta 2-X Starting with Position Two in Sporadic Alzheimer's Disease Cases and Two Alzheimer Mouse Models.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  207. SPIEGEL J, Pirraglia E, Li Y, Tsui W, et al
    Greater Specificity for Cerebrospinal Fluid P-tau231 over P-tau181 in the Differentiation of Healthy Controls from Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  208. KIM HJ, Park KW, Kim TE, Im JY, et al
    Elevation of the Plasma Abeta40/Abeta 42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  209. SAVASTANO A, Klafki H, Haussmann U, Oberstein TJ, et al
    N-Truncated Abeta2-X Starting with Position Two in Sporadic Alzheimer's Disease Cases and Two Alzheimer Mouse Models.
    J Alzheimers Dis. 2015;49:101-10.
    PubMed     Text format     Abstract available


  210. BRYNDIS EINARSDOTTIR A, Hardarson SH, Kristjansdottir JV, Bragason DT, et al
    Retinal Oximetry Imaging in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  211. TRIPLETT JC, Swomley AM, Cai J, Klein JB, et al
    Quantitative Phosphoproteomic Analyses of the Inferior Parietal Lobule from Three Different Pathological Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  212. LIU H, Qiu H, Xiao Q, Le W, et al
    Chronic Hypoxia-Induced Autophagy Aggravates the Neuropathology of Alzheimer's Disease through AMPK-mTOR Signaling in the APPSwe/PS1dE9 Mouse Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  213. SPARRE-SORENSEN M, Kristensen G
    Alzheimer's Disease in the Danish Malnutrition Period 1999-2007.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  214. MOON SW, Dinov ID, Kim J, Zamanyan A, et al
    Structural Neuroimaging Genetics Interactions in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  215. ZHENG W, Yao Z, Hu B, Gao X, et al
    Novel Cortical Thickness Pattern for Accurate Detection of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  216. TORMALEHTO SM, Martikainen JA, Vaatainen ST, Hallikainen IT, et al
    Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  217. CALDERON-GARCIDUENAS L, Mora-Tiscareno A, Sanchez GM, Rodriguez-Diaz J, et al
    A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE varepsilon4 Mexico City Children and Their Parents.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  218. PRICE CC, Tanner JJ, Schmalfuss IM, Brumback B, et al
    Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  219. BIELARCZYK H, Jankowska-Kulawy A, Hofling C, Ronowska A, et al
    AbetaPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  220. MISTRIDIS P, Krumm S, Monsch AU, Berres M, et al
    The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  221. JHA NK, Jha SK, Kumar D, Kejriwal N, et al
    Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  222. GIACCONE G
    The Existence of Primary Age-Related Tauopathy Suggests that not all the Cases with Early Braak Stages of Neurofibrillary Pathology are Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  223. DIEHL-WIESENECKER E, von Armin CA, Dupuis L, Muller HP, et al
    Adipose Tissue Distribution in Patients with Alzheimer's Disease: A Whole Body MRI Case-Control Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  224. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:557-61.
    PubMed     Text format    


  225. REDDY PH, Blackmon J, Molinar-Lopez V, Ament C, et al
    Garrison Institute on Aging: A New Hope for Elderly Individuals and Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:547-55.
    PubMed     Text format     Abstract available


  226. WOOD PL, Medicherla S, Sheikh N, Terry B, et al
    Targeted Lipidomics of Fontal Cortex and Plasma Diacylglycerols (DAG) in Mild Cognitive Impairment and Alzheimer's Disease: Validation of DAG Accumulation Early in the Pathophysiology of Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:537-46.
    PubMed     Text format     Abstract available


  227. EL HAJ M, Gely-Nargeot MC, Raffard S
    Destination Memory and Cognitive Theory of Mind in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:529-36.
    PubMed     Text format     Abstract available


  228. SAMURAKI M, Matsunari I, Yoshita M, Shima K, et al
    Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:517-28.
    PubMed     Text format     Abstract available


  229. SARAJARVI T, Marttinen M, Natunen T, Kauppinen T, et al
    Genetic Variation in delta-Opioid Receptor Associates with Increased beta- and gamma-Secretase Activity in the Late Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:507-16.
    PubMed     Text format     Abstract available


  230. SARLUS H, Eyjolfsdottir H, Eriksdotter M, Oprica M, et al
    Influence of Allergy on Immunoglobulins and Amyloid-beta in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:495-505.
    PubMed     Text format     Abstract available


  231. GAUTHIER S, Rountree S, Finn B, LaPlante B, et al
    Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study.
    J Alzheimers Dis. 2015;48:473-81.
    PubMed     Text format     Abstract available


  232. LIAO X, Li G, Wang A, Liu T, et al
    Repetitive Transcranial Magnetic Stimulation as an Alternative Therapy for Cognitive Impairment in Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2015;48:463-72.
    PubMed     Text format     Abstract available


  233. LEIFERT WR, Nguyen T, Rembach A, Martins R, et al
    Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.
    J Alzheimers Dis. 2015;48:443-52.
    PubMed     Text format     Abstract available


  234. LEWCZUK P, Kornhuber J, Toledo JB, Trojanowski JQ, et al
    Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia Subjects.
    J Alzheimers Dis. 2015;48:433-41.
    PubMed     Text format     Abstract available


  235. WEISE D, Tiepolt S, Awissus C, Hoffmann KT, et al
    Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.
    J Alzheimers Dis. 2015;48:425-32.
    PubMed     Text format     Abstract available


  236. KEENEY JT, Ibrahimi S, Zhao L
    Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    J Alzheimers Dis. 2015;48:411-24.
    PubMed     Text format     Abstract available


  237. MATSUNAGA S, Kishi T, Annas P, Basun H, et al
    Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2015;48:403-10.
    PubMed     Text format     Abstract available


  238. SERVELLO A, Fioretti A, Gualdi G, Di Biasi C, et al
    Olfactory Dysfunction, Olfactory Bulb Volume and Alzheimer's Disease: Is There a Correlation? A Pilot Study1.
    J Alzheimers Dis. 2015;48:395-402.
    PubMed     Text format     Abstract available


  239. REA R, Carotenuto A, Traini E, Fasanaro AM, et al
    Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.
    J Alzheimers Dis. 2015;48:377-83.
    PubMed     Text format     Abstract available


  240. BEYDOUN MA, Beydoun HA, Gamaldo AA, Rostant OS, et al
    Nationwide Inpatient Prevalence, Predictors, and Outcomes of Alzheimer's Disease among Older Adults in the United States, 2002-2012.
    J Alzheimers Dis. 2015;48:361-75.
    PubMed     Text format     Abstract available


  241. HARRIS SA, Harris EA
    Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:319-53.
    PubMed     Text format     Abstract available


  242. PISTOLLATO F, Cano SS, Elio I, Vergara MM, et al
    The Use of Neuroimaging to Assess Associations Among Diet, Nutrients, Metabolic Syndrome, and Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:303-18.
    PubMed     Text format     Abstract available


  243. DUBNER L, Wang J, Ho L, Ward L, et al
    Recommendations for Development of New Standardized Forms of Cocoa Breeds and Cocoa Extract Processing for the Prevention of Alzheimer's Disease: Role of Cocoa in Promotion of Cognitive Resilience and Healthy Brain Aging.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  244. POPOVA SN, Pesala S, Alafuzoff I
    To Stage Alzheimer's Disease Related Neurodegeneration Using one Section of Hippocampus.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  245. DI STEFANO F, Epelbaum S, Coley N, Cantet C, et al
    Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  246. DUITS FH, Hernandez-Guillamon M, Montaner J, Goos JD, et al
    Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  247. ERIKSDOTTER M, Vedin I, Falahati F, Freund-Levi Y, et al
    Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  248. YOU SC, Walsh CM, Chiodo LA, Ketelle R, et al
    Neuropsychiatric Symptoms Predict Functional Status in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  249. FORAKER J, Millard SP, Leong L, Thomson Z, et al
    The APOE Gene is Differentially Methylated in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  250. BILELLO M, Doshi J, Nabavizadeh SA, Toledo JB, et al
    Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  251. MAGISTRI M, Velmeshev D, Makhmutova M, Faghihi MA, et al
    Transcriptomics Profiling of Alzheimer's Disease Reveal Neurovascular Defects, Altered Amyloid-beta Homeostasis, and Deregulated Expression of Long Noncoding RNAs.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  252. KUBO M, Kishi T, Matsunaga S, Iwata N, et al
    Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  253. HONG HS, Maezawa I, Petrlova J, Zhao XY, et al
    Tomoregulin (TMEFF2) Binds Alzheimer's Disease Amyloid-beta (Abeta) Oligomer and AbetaPP and Protects Neurons from Abeta-Induced Toxicity.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  254. MEIER S, Bell M, Lyons DN, Ingram A, et al
    Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  255. GRAMUNT N, Buschke H, Sanchez-Benavides G, Lipton RB, et al
    Reference Data of the Spanish Memory Binding Test in a Midlife Population from the ALFA STUDY (Alzheimer's and Family).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  256. MENENDEZ-GONZALEZ M, de Celis Alonso B, Salas-Pacheco J, Arias-Carrion O, et al
    Structural Neuroimaging of the Medial Temporal Lobe in Alzheimer's Disease Clinical Trials.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  257. MATSUZONO K, Sato K, Kono S, Hishikawa N, et al
    Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


    August 2015

  258. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:287-91.
    PubMed     Text format    


  259. MATSUZONO K, Hishikawa N, Yamashita T, Ohta Y, et al
    Comprehensive Clinical Evaluations of Frontotemporal Dementia Contrasting to Alzheimer's Disease (oFTD Study).
    J Alzheimers Dis. 2015;48:279-86.
    PubMed     Text format     Abstract available


  260. ANDERKOVA L, Eliasova I, Marecek R, Janousova E, et al
    Distinct Pattern of Gray Matter Atrophy in Mild Alzheimer's Disease Impacts on Cognitive Outcomes of Noninvasive Brain Stimulation.
    J Alzheimers Dis. 2015;48:251-60.
    PubMed     Text format     Abstract available


  261. HEISKANEN J, Hartikainen S, Roine RP, Tolppanen AM, et al
    30-Day Mortality after Cardiovascular Events in Persons with or without Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:241-9.
    PubMed     Text format     Abstract available


  262. BRUEGGEN K, Dyrba M, Barkhof F, Hausner L, et al
    Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    J Alzheimers Dis. 2015;48:197-204.
    PubMed     Text format     Abstract available


  263. SCHMIDT C, Gerlach N, Schmitz M, Thom T, et al
    Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:189-96.
    PubMed     Text format     Abstract available


  264. LI QX, Villemagne VL, Doecke JD, Rembach A, et al
    Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-beta Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    J Alzheimers Dis. 2015;48:175-87.
    PubMed     Text format     Abstract available


  265. PAPUC E, Kurys-Denis E, Krupski W, Tatara M, et al
    Can Antibodies Against Glial Derived Antigens be Early Biomarkers of Hippocampal Demyelination and Memory Loss in Alzheimer's Disease?
    J Alzheimers Dis. 2015;48:115-21.
    PubMed     Text format     Abstract available


  266. ZHANG XF, Zhao YF, Zhu SW, Huang WJ, et al
    CXCL1 Triggers Caspase-3 Dependent Tau Cleavage in Long-Term Neuronal Cultures and in the Hippocampus of Aged Mice: Implications in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:89-104.
    PubMed     Text format     Abstract available


  267. SNIR JA, Suchy M, Lawrence KS, Hudson RH, et al
    Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:73-87.
    PubMed     Text format     Abstract available


  268. SOLLVANDER S, Ekholm-Pettersson F, Brundin RM, Westman G, et al
    Increased Number of Plasma B Cells Producing Autoantibodies Against Abeta42 Protofibrils in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:63-72.
    PubMed     Text format     Abstract available


  269. SIARKOS KT, Katirtzoglou EA, Politis AM
    A Review of Pharmacological Treatments for Depression in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:15-34.
    PubMed     Text format     Abstract available


  270. WESSON ASHFORD J, Mahoney L, Burkett T
    A Role for Complementary and Integrative Medicine in Alzheimer's Disease Prevention.
    J Alzheimers Dis. 2015;48:13-4.
    PubMed     Text format     Abstract available


  271. KHALSA DS
    Stress, Meditation, and Alzheimer's Disease Prevention: Where The Evidence Stands.
    J Alzheimers Dis. 2015;48:1-12.
    PubMed     Text format     Abstract available


  272. SPALLETTA G, Long JD, Robinson RG, Trequattrini A, et al
    Longitudinal Neuropsychiatric Predictors of Death in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  273. ABERG D, Johansson P, Isgaard J, Wallin A, et al
    Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  274. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:1079-84.
    PubMed     Text format    


  275. TRAVASSOS M, Santana I, Baldeiras I, Tsolaki M, et al
    Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-beta Levels in Patients with Alzheimer's Disease?
    J Alzheimers Dis. 2015;47:1069-78.
    PubMed     Text format     Abstract available


  276. ZHAN Y, Chen K, Wu X, Zhang D, et al
    Identification of Conversion from Normal Elderly Cognition to Alzheimer's Disease using Multimodal Support Vector Machine.
    J Alzheimers Dis. 2015;47:1057-67.
    PubMed     Text format     Abstract available


  277. LIU K, Chojnacki JE, Wade EE, Saathoff JM, et al
    Bivalent Compound 17MN Exerts Neuroprotection through Interaction at Multiple Sites in a Cellular Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:1021-33.
    PubMed     Text format     Abstract available


  278. GLEASON CE, Fischer BL, Dowling NM, Setchell KD, et al
    Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:1009-19.
    PubMed     Text format     Abstract available


  279. WEILER M, Agosta F, Canu E, Copetti M, et al
    Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    J Alzheimers Dis. 2015;47:995-1007.
    PubMed     Text format     Abstract available


  280. MENDEZ MF, Paholpak P, Lin A, Zhang JY, et al
    Prevalence of Traumatic Brain Injury in Early Versus Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:985-93.
    PubMed     Text format     Abstract available


  281. QUIROZ YT, Willment KC, Castrillon G, Muniz M, et al
    Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:955-64.
    PubMed     Text format     Abstract available


  282. FU Y, Zhao D, Pan B, Wang J, et al
    Proteomic Analysis of Protein Expression Throughout Disease Progression in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:915-26.
    PubMed     Text format     Abstract available


  283. LI G, Xiong K, Korff A, Pan C, et al
    Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Abeta42 and Tau.
    J Alzheimers Dis. 2015;47:883-7.
    PubMed     Text format     Abstract available


  284. CATANIA M, Di Fede G, Tonoli E, Benussi L, et al
    Mirror Image of the Amyloid-beta Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:877-81.
    PubMed     Text format     Abstract available


  285. ALONSO R, Pisa D, Rabano A, Rodal I, et al
    Cerebrospinal Fluid from Alzheimer's Disease Patients Contains Fungal Proteins and DNA.
    J Alzheimers Dis. 2015;47:873-6.
    PubMed     Text format     Abstract available


  286. NOVAIS F, Starkstein S
    Phenomenology of Depression in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:845-55.
    PubMed     Text format     Abstract available


  287. BANIK A, Brown RE, Bamburg J, Lahiri DK, et al
    Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?1.
    J Alzheimers Dis. 2015;47:815-43.
    PubMed     Text format     Abstract available



  288. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:787-91.
    PubMed     Text format    


  289. VALOTASSIOU V, Papatriantafyllou J, Sifakis N, Tzavara C, et al
    Clinical Evaluation of Brain Perfusion SPECT with Brodmann Areas Mapping in Early Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:773-85.
    PubMed     Text format     Abstract available


  290. BRADLEY-WHITMAN MA, Abner E, Lynn BC, Lovell MA, et al
    A Novel Plasma Based Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:761-71.
    PubMed     Text format     Abstract available


  291. CHIAM JT, Lunnon K, Voyle N, Proitsi P, et al
    No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:741-50.
    PubMed     Text format     Abstract available


  292. NORDBERG A, Kadir A, Andreasen N, Almkvist O, et al
    Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment.
    J Alzheimers Dis. 2015;47:691-704.
    PubMed     Text format     Abstract available


  293. JENSEN-DAHM C, Waldemar G, Staehelin Jensen T, Malmqvist L, et al
    Autonomic Dysfunction in Patients with Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:681-9.
    PubMed     Text format     Abstract available


  294. TANG X, Holland D, Dale AM, Miller MI, et al
    APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters.
    J Alzheimers Dis. 2015;47:645-60.
    PubMed     Text format     Abstract available


  295. CHO SJ, Yun SM, Lee DH, Jo C, et al
    Plasma SUMO1 Protein is Elevated in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:639-43.
    PubMed     Text format     Abstract available


  296. VIRK SA, Eslick GD
    Aluminum Levels in Brain, Serum, and Cerebrospinal Fluid are Higher in Alzheimer's Disease Cases than in Controls: A Series of Meta-Analyses.
    J Alzheimers Dis. 2015;47:629-38.
    PubMed     Text format     Abstract available


  297. NAKANO Y, Matsuzono K, Yamashita T, Ohta Y, et al
    Long-Term Efficacy of Galantamine in Alzheimer's Disease: The Okayama Galantamine Study (OGS).
    J Alzheimers Dis. 2015;47:609-17.
    PubMed     Text format     Abstract available


  298. WANG ZX, Tan L, Wang HF, Ma J, et al
    Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses.
    J Alzheimers Dis. 2015;47:565-81.
    PubMed     Text format     Abstract available


  299. TIEPOLT S, Patt M, Hoffmann KT, Schroeter ML, et al
    Alzheimer's Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject.
    J Alzheimers Dis. 2015;47:539-43.
    PubMed     Text format     Abstract available


  300. FLORIS G, Di Stefano F, Cherchi MV, Costa G, et al
    Multiple Spontaneous Cerebral Microbleeds and Leukoencephalopathy in PSEN1-Associated Familial Alzheimer's Disease: Mirror of Cerebral Amyloid Angiopathy?
    J Alzheimers Dis. 2015;47:535-8.
    PubMed     Text format     Abstract available


    July 2015

  301. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:531-4.
    PubMed     Text format    


  302. GIIL LM, Kristoffersen EK, Vedeler CA, Aarsland D, et al
    Autoantibodies Toward the Angiotensin 2 Type 1 Receptor: A Novel Autoantibody in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:523-9.
    PubMed     Text format     Abstract available


  303. YIN RH, Tan L, Liu Y, Wang WY, et al
    Multimodal Voxel-Based Meta-Analysis of White Matter Abnormalities in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:495-507.
    PubMed     Text format     Abstract available


  304. MATSUZONO K, Yamashita T, Ohta Y, Hishikawa N, et al
    Clinical Benefits of Memantine Treatment for Alzheimer's Disease in the Okayama Memantine Study II (OMS II).
    J Alzheimers Dis. 2015;47:487-93.
    PubMed     Text format     Abstract available


  305. LEON C, Pin S, Kreft-Jais C, Arwidson P, et al
    Perceptions of Alzheimer's Disease in the French Population: Evolutions between 2008 and 2013 and Associated Factors in 2013.
    J Alzheimers Dis. 2015;47:467-78.
    PubMed     Text format     Abstract available


  306. RANGASAMY SB, Corbett GT, Roy A, Modi KK, et al
    Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:385-402.
    PubMed     Text format     Abstract available


  307. PIMENTEL LS, Allard S, Do Carmo S, Weinreb O, et al
    The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:373-83.
    PubMed     Text format     Abstract available


  308. HARTL D, Gu W, Mayhaus M, Pichler S, et al
    Amyloid-beta Protein Precursor Cleavage Products in Postmortem Ventricular Cerebrospinal Fluid of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2015;47:365-72.
    PubMed     Text format     Abstract available


  309. STEEL AJ, Eslick GD
    Herpes Viruses Increase the Risk of Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2015;47:351-64.
    PubMed     Text format     Abstract available


  310. ROMAN GC
    MTHFR Gene Mutations: A Potential Marker of Late-Onset Alzheimer's Disease?
    J Alzheimers Dis. 2015;47:323-7.
    PubMed     Text format     Abstract available


  311. LISTA S, O'Bryant SE, Blennow K, Dubois B, et al
    Biomarkers in Sporadic and Familial Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:291-317.
    PubMed     Text format     Abstract available


  312. KINCSES ZT, Kiraly A, Vereb D, Vecsei L, et al
    Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models.
    J Alzheimers Dis. 2015;47:277-90.
    PubMed     Text format     Abstract available



  313. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:273-6.
    PubMed     Text format    



  314. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
    J Alzheimers Dis. 2015;47:271.
    PubMed     Text format    


  315. VAN HARTEN AC, Mulders J, Scheltens P, van der Flier WM, et al
    Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:243-52.
    PubMed     Text format     Abstract available


  316. EDMONDS EC, Delano-Wood L, Galasko DR, Salmon DP, et al
    Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:231-42.
    PubMed     Text format     Abstract available


  317. LIU-SEIFERT H, Siemers E, Price K, Han B, et al
    Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:205-14.
    PubMed     Text format     Abstract available


  318. NAKAMAGOE K, Fujimiya S, Koganezawa T, Kadono K, et al
    Vestibular Function Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:185-96.
    PubMed     Text format     Abstract available


  319. BUSSE S, Steiner J, Alter J, Dobrowolny H, et al
    Expression of HLA-DR, CD80, and CD86 in Healthy Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:177-84.
    PubMed     Text format     Abstract available


  320. WANG Q, Jia J, Qin W, Wu L, et al
    A Novel AbetaPP M722K Mutation Affects Amyloid-beta Secretion and Tau Phosphorylation and May Cause Early-Onset Familial Alzheimer's Disease in Chinese Individuals.
    J Alzheimers Dis. 2015;47:157-65.
    PubMed     Text format     Abstract available


  321. WESSON ASHFORD J
    Treatment of Alzheimer's Disease: The Legacy of the Cholinergic Hypothesis, Neuroplasticity, and Future Directions.
    J Alzheimers Dis. 2015;47:149-56.
    PubMed     Text format     Abstract available


  322. WARING JF, Tang Q, Robieson WZ, King DP, et al
    APOE-varepsilon4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:137-48.
    PubMed     Text format     Abstract available


  323. JOHNSON LA, Gamboa A, Vintimilla R, Cheatwood AJ, et al
    Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans.
    J Alzheimers Dis. 2015;47:129-36.
    PubMed     Text format     Abstract available


  324. RUDNITSKAYA EA, Muraleva NA, Maksimova KY, Kiseleva E, et al
    Melatonin Attenuates Memory Impairment, Amyloid-beta Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:103-16.
    PubMed     Text format     Abstract available


  325. ATWOOD CS, Bowen RL
    A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2015;47:33-47.
    PubMed     Text format     Abstract available


  326. GROBLEWSKA M, Muszynski P, Wojtulewska-Supron A, Kulczynska-Przybik A, et al
    The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:17-32.
    PubMed     Text format     Abstract available


  327. MOOSAVI B, Mousavi B, Macreadie IG
    Yeast Model of Amyloid-beta and Tau Aggregation in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:9-16.
    PubMed     Text format     Abstract available


    June 2015

  328. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:1129-33.
    PubMed     Text format    


  329. GUSTAFSON DR, Clare Morris M, Scarmeas N, Shah RC, et al
    New Perspectives on Alzheimer's Disease and Nutrition.
    J Alzheimers Dis. 2015;46:1111-27.
    PubMed     Text format     Abstract available


  330. JONGBLOED W, van Dijk KD, Mulder SD, van de Berg WD, et al
    Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:1103-10.
    PubMed     Text format     Abstract available


  331. BURNHAM SC, Raghavan N, Wilson W, Baker D, et al
    Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study.
    J Alzheimers Dis. 2015;46:1079-89.
    PubMed     Text format     Abstract available


  332. WANG H, Tan L, Wang HF, Liu Y, et al
    Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2015;46:1049-70.
    PubMed     Text format     Abstract available


  333. ASSELINEAU D, Benlhassan K, Arosio B, Mari D, et al
    Interleukin-10 Production in Response to Amyloid-beta Differs between Slow and Fast Decliners in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:837-42.
    PubMed     Text format     Abstract available


  334. KHAN TK, Alkon DL
    Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.
    J Alzheimers Dis. 2015;46:817-36.
    PubMed     Text format     Abstract available



  335. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:813-6.
    PubMed     Text format    


  336. TEDONE E, Arosio B, Colombo F, Ferri E, et al
    Leukocyte Telomere Length in Alzheimer's Disease Patients with a Different Rate of Progression.
    J Alzheimers Dis. 2015;46:761-9.
    PubMed     Text format     Abstract available


  337. MATSUZONO K, Yamashita T, Ohta Y, Hishikawa N, et al
    Clinical Benefits for Older Alzheimer's Disease Patients: Okayama Late Dementia Study (OLDS).
    J Alzheimers Dis. 2015;46:687-93.
    PubMed     Text format     Abstract available


  338. MOODLEY KK, Perani D, Minati L, Anthony Della Rosa P, et al
    Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
    J Alzheimers Dis. 2015;46:639-53.
    PubMed     Text format     Abstract available


    May 2015

  339. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:549-52.
    PubMed     Text format    


  340. WANG C, Tan L, Wang HF, Yu WJ, et al
    Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:491-5.
    PubMed     Text format     Abstract available


  341. TERNI B, Ferrer I
    Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer's Disease-Related Pathology.
    J Alzheimers Dis. 2015;46:461-9.
    PubMed     Text format     Abstract available



  342. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:285-7.
    PubMed     Text format    


    April 2015
  343. WURTMAN RJ
    How Anticholinergic Drugs Might Promote Alzheimer's Disease: More Amyloid-beta and Less Phosphatidylcholine.
    J Alzheimers Dis. 2015;46:983-7.
    PubMed     Text format     Abstract available


  344. ZHANG WI, Antonios G, Rabano A, Bayer TA, et al
    Super-Resolution Microscopy of Cerebrospinal Fluid Biomarkers as a Tool for Alzheimer's Disease Diagnostics.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  345. PISCOPO P, Tosto G, Belli C, Talarico G, et al
    SORL1 Gene is Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  346. YEO HG, Lee Y, Jeon CY, Jeong KJ, et al
    Characterization of Cerebral Damage in a Monkey Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Streptozotocin.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  347. COART E, Barrado LG, Duits FH, Scheltens P, et al
    Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  348. OLESON S, Murphy C
    Olfactory Dysfunction in ApoE epsilon4/4 Homozygotes with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  349. HANSEN HH, Fabricius K, Barkholt P, Niehoff ML, et al
    The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  350. BOCCIA M, Acierno M, Piccardi L
    Neuroanatomy of Alzheimer's Disease and Late-Life Depression: A Coordinate-Based Meta-Analysis of MRI Studies.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  351. KONG D, Giovanello KS, Wang Y, Lin W, et al
    Predicting Alzheimer's Disease Using Combined Imaging-Whole Genome SNP Data.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  352. SHEN L, Ji HF
    Associations between Homocysteine, Folic Acid, Vitamin B12 and Alzheimer's Disease: Insights from Meta-Analyses.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  353. BREWER GJ
    Divalent Copper as a Major Triggering Agent in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  354. ELLIS B, Hye A, Snowden SG
    Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  355. PUSSWALD G, Lehrner J, Hagmann M, Dal-Bianco P, et al
    Gender-Specific Differences in Cognitive Profiles of Patients with Alzheimer's Disease: Results of the Prospective Dementia Registry Austria (PRODEM-Austria).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  356. VILLA C, Ferini-Strambi L, Combi R
    The Synergistic Relationship between Alzheimer's Disease and Sleep Disorders: An Update.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  357. AVAN A, Hoogenraad TU
    Zinc and Copper in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


    March 2015
  358. ALTAMURA C, Ventriglia M, Martini MG, Montesano D, et al
    Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer's Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  359. O'DAY DH, Eshak K, Myre MA
    Calmodulin Binding Proteins and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  360. SAVAGE MJ, Holder DJ, Wu G, Kaplow J, et al
    Soluble BACE-1 Activity and sAbetaPPbeta Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  361. PORTBURY SD, Adlard PA
    Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer's Disease: Common Pathologies Potentiated by Altered Zinc Homeostasis.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  362. BALDUCCI C, Paladini A, Micotti E, Tolomeo D, et al
    The Continuing Failure of Bexarotene in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  363. DE LA TORRE JC
    Do We Try Mending Humpty Dumpty or Prevent His Fall? An Alzheimer's Disease Dilemma.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  364. KORTVELYESSY P, Gukasjan A, Sweeny-Reed C, Heinze HJ, et al
    Progranulin and Amyloid-beta Levels: Relationship to Neuropsychology in Frontotemporal and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  365. SEAMAN JB, Terhorst L, Gentry A, Hunsaker A, et al
    Psychometric Properties of a Decisional Capacity Screening Tool for Individuals Contemplating Participation in Alzheimer's Disease Research.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  366. GAGO MF, Fernandes V, Ferreira J, Yelshyna D, et al
    Role of the Visual and Auditory Systems in Postural Stability in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  367. VELAYUDHAN L, Gasper A, Pritchard M, Baillon S, et al
    Pattern of Smell Identification Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  368. WOJSIAT J, Prandelli C, Laskowska-Kaszub K, Martin-Requero A, et al
    Oxidative Stress and Aberrant Cell Cycle in Alzheimer's Disease Lymphocytes: Diagnostic Prospects.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  369. BUDOLFSON K, Malek-Ahmadi M, Belden CM, Powell J, et al
    Neuropsychological Correlates of the Alzheimer's Questionnaire.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  370. NIJHOLT DA, Ijsselstijn L, van der Weiden MM, Zheng PP, et al
    Pregnancy Zone Protein is Increased in the Alzheimer's Disease Brain and Associates with Senile Plaques.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  371. MIGLIACCIO R, Agosta F, Possin KL, Canu E, et al
    Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  372. JANG H, Kim JH, Choi SH, Lee Y, et al
    Body Mass Index and Mortality Rate in Korean Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


    February 2015
  373. DI MARCO LY, Farkas E, Martin C, Venneri A, et al
    Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease?
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  374. ZEIFMAN LE, Eddy WF, Lopez OL, Kuller LH, et al
    Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  375. DINKINS MB, Dasgupta S, Wang G, Zhu G, et al
    The 5XFAD Mouse Model of Alzheimer's Disease Exhibits an Age-Dependent Increase in Anti-Ceramide IgG and Exogenous Administration of Ceramide Further Increases Anti-Ceramide Titers and Amyloid Plaque Burden.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  376. THEOFILAS P, Dunlop S, Heinsen H, Grinberg LT, et al
    Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  377. BACCHETTI T, Vignini A, Giulietti A, Nanetti L, et al
    Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  378. BIK-MULTANOWSKI M, Pietrzyk JJ, Midro A
    MTRNR2L12: A Candidate Blood Marker of Early Alzheimer's Disease-Like Dementia in Adults with Down Syndrome.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  379. BHATTACHARYA S, Maelicke A, Montag D
    Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer's Disease Mice.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  380. BREGMAN N, Regev K, Moore O, Giladi N, et al
    A Simple Tool to Reach Populations at Risk for Developing Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  381. LI G, Kim C, Kim J, Yoon H, et al
    Common Pesticide, Dichlorodiphenyltrichloroethane (DDT), Increases Amyloid-beta Levels by Impairing the Function of ABCA1 and IDE: Implication for Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  382. LE PAGE A, Bourgade K, Lamoureux J, Frost E, et al
    NK Cells are Activated in Amnestic Mild Cognitive Impairment but not in Mild Alzheimer's Disease Patients.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  383. RICE AC, Ladd AC, Bennett Jr JP
    Postmortem Alzheimer's Disease Hippocampi Show Oxidative Phosphorylation Gene Expression Opposite that of Isolated Pyramidal Neurons.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  384. BOULEAU S, Tricoire H
    Drosophila Models of Alzheimer's Disease: Advances, Limits, and Perspectives.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  385. KOWOLL ME, Degen C, Gladis S, Schroder J, et al
    Neuropsychological Profiles and Verbal Abilities in Lifelong Bilinguals with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  386. VENTRIGLIA M, Brewer GJ, Simonelli I, Mariani S, et al
    Zinc in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  387. CAMPBELL SN, Zhang C, Roe AD, Lee N, et al
    Impact of CRFR1 Ablation on Amyloid-beta Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  388. WISSE LE, Reijmer YD, Ter Telgte A, Kuijf HJ, et al
    Hippocampal Disconnection in Early Alzheimer's Disease: A 7 Tesla MRI Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  389. LEE D, Kim WC, Charidimou A, Song M, et al
    A Bird's-Eye View of Alzheimer's Disease Research: Reflecting Different Perspectives of Indexers, Authors, or Citers in Mapping the Field.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  390. RICHARD BC, Kurdakova A, Baches S, Bayer TA, et al
    Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  391. DONOVAN NJ, Hsu DC, Dagley AS, Schultz AP, et al
    Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  392. WANG Y, Wang Y, Sui Y, Yu H, et al
    The Combination of Aricept with a Traditional Chinese Medicine Formula, Smart Soup, May Be a Novel Way to Treat Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  393. QIN W, Jia X, Wang F, Zuo X, et al
    Elevated Plasma Angiogenesis Factors in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  394. PERSICHILLI S, Gervasoni J, Di Napoli A, Fuso A, et al
    Plasma Thiols Levels in Alzheimer's Disease Mice under Diet-Induced Hyperhomocysteinemia: Effect of S-Adenosylmethionine and Superoxide-Dismutase Aupplementation.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  395. BOUVIER DS, Murai KK
    Synergistic Actions of Microglia and Astrocytes in the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  396. OLAZARAN J, Gil-de-Gomez L, Rodriguez-Martin A, Valenti-Soler M, et al
    A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  397. WRIGHT JW, Harding JW
    The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  398. DI PAOLA M, Phillips O, Orfei MD, Piras F, et al
    Corpus Callosum Structure is Topographically Correlated with the Early Course of Cognition and Depression in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  399. CASAMENTI F, Grossi C, Rigacci S, Pantano D, et al
    Oleuropein Aglycone: A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  400. WHITWELL JL, Kantarci K, Weigand SD, Lundt ES, et al
    Microbleeds in Atypical Presentations of Alzheimer's Disease: A Comparison to Dementia of the Alzheimer's Type.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  401. DARST BF, Koscik RL, Hermann BP, La Rue A, et al
    Heritability of Cognitive Traits Among Siblings with a Parental History of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  402. LEUZY A, Carter SF, Chiotis K, Almkvist O, et al
    Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  403. KHONDOKER M, Newhouse S, Westman E, Muehlboeck JS, et al
    Linking Genetics of Brain Changes to Alzheimer's Disease: Sparse Whole Genome Association Scan of Regional MRI Volumes in the ADNI and AddNeuroMed Cohorts.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  404. WANG X, Lopez O, Sweet RA, Becker JT, et al
    Genetic Determinants of Survival in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  405. ZHANG C, Kuo CC, Moghadam SH, Monte L, et al
    Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer's Disease Transgenic Mouse Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


    January 2015
  406. BROMMELHOFF JA, Sultzer DL
    Brain Structure and Function Related to Depression in Alzheimer's Disease: Contributions from Neuroimaging Research.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  407. BURATTI L, Balestrini S, Altamura C, Viticchi G, et al
    Markers for the Risk of Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  408. PERRONE L, Grant WB
    Observational and Ecological Studies of Dietary Advanced Glycation End Products in National Diets and Alzheimer's Disease Incidence and Prevalence.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  409. ELAHI S, Bachman AH, Lee SH, Sidtis JJ, et al
    Corpus Callosum Atrophy Rate in Mild Cognitive Impairment and Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  410. VASAVADA MM, Wang J, Eslinger PJ, Gill DJ, et al
    Olfactory Cortex Degeneration in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  411. BERISHA V, Wang S, LaCross A, Liss J, et al
    Tracking Discourse Complexity Preceding Alzheimer's Disease Diagnosis: A Case Study Comparing the Press Conferences of Presidents Ronald Reagan and George Herbert Walker Bush.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  412. HULL J, Patel V, El Hindy M, Lee C, et al
    Regional Increase in the Expression of the BCAT Proteins in Alzheimer's Disease Brain: Implications in Glutamate Toxicity.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  413. LEE DY, Moon J, Lee ST, Jung KH, et al
    Distinct Expression of Long Non-Coding RNAs in an Alzheimer's Disease Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  414. WANG X, Wang J, He Y, Li H, et al
    Apolipoprotein E epsilon4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  415. YANG H, Guan H, Yang M, Liu Z, et al
    Upregulation of Mitochondrial Ferritin by Proinflammatory Cytokines: Implications for a Role in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  416. MATSUZONO K, Hishikawa N, Ohta Y, Yamashita T, et al
    Combination Therapy of Cholinesterase Inhibitor (Donepezil or Galantamine) plus Memantine in the Okayama Memantine Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  417. INZELBERG R, Massarwa M, Schechtman E, Strugatsky R, et al
    Estimating the Risk for Conversion from Mild Cognitive Impairment to Alzheimer's Disease in an Elderly Arab Community.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  418. REMBACH A, Stingo FC, Peterson C, Vannucci M, et al
    Bayesian Graphical Network Analyses Reveal Complex Biological Interactions Specific to Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  419. PAN C, Korff A, Galasko D, Ginghina C, et al
    Diagnostic Values of Cerebrospinal Fluid T-Tau and Abeta42 using Meso Scale Discovery Assays for Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  420. MORENO-GRAU S, Barneda B, Carriba P, Marin J, et al
    Evaluation of Candidate Genes Related to Neuronal Apoptosis in Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  421. MEEKER KD, Meabon JS, Cook DG
    Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  422. MIRANDA LF, Gomes KB, Silveira JN, Pianetti GA, et al
    Predictive Factors of Clinical Response to Cholinesterase Inhibitors in Mild and Moderate Alzheimer's Disease and Mixed Dementia: A One-Year Naturalistic Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  423. MOYSE E, Bastin C, Salmon E, Bredart S, et al
    Impairment of Age Estimation from Faces in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  424. PISTONO A, Jucla M, Barbeau EJ, Saint-Aubert L, et al
    Pauses During Autobiographical Discourse Reflect Episodic Memory Processes in Early Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  425. AGOSTINHO P, Pliassova A, Oliveira CR, Cunha RA, et al
    Localization and Trafficking of Amyloid-beta Protein Precursor and Secretases: Impact on Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  426. ZHANG H, Liu J, Sun S, Pchitskaya E, et al
    Calcium Signaling, Excitability, and Synaptic Plasticity Defects in Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  427. VOROBYOV V, Kaptsov V, Gordon R, Makarova E, et al
    Neuroprotective Effects of Hydrated Fullerene C60: Cortical and Hippocampal EEG Interplay in an Amyloid-Infused Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  428. REMINGTON R, Bechtel C, Larsen D, Samar A, et al
    A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  429. WILLIAMS MA, Haughton D, Stevenson M, Craig D, et al
    Plasma Complement factor H in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  430. CRETIN B, Di Bitonto L, Blanc F, Magnin E, et al
    Left Temporal Lobe Epilepsy Revealing Left Posterior Cortical Atrophy Due to Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  431. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;43:337-9.
    PubMed     Text format    



  432. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;43:699-700.
    PubMed     Text format    



  433. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;43:1093-5.
    PubMed     Text format    



  434. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;43:1451-3.
    PubMed     Text format    



  435. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;44:339-41.
    PubMed     Text format    



  436. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;44:721-3.
    PubMed     Text format    



  437. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;44:1035-7.
    PubMed     Text format    



  438. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;44:1375-7.
    PubMed     Text format    


  439. ZHAN X, Jickling GC, Ander BP, Stamova B, et al
    Myelin Basic Protein Associates with AbetaPP, Abeta1-42, and Amyloid Plaques in Cortex of Alzheimer's Disease Brain.
    J Alzheimers Dis. 2015;44:1213-29.
    PubMed     Text format     Abstract available



  440. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;45:321-4.
    PubMed     Text format    



  441. Upcoming meetings related to Alzheimer's diseasew.
    J Alzheimers Dis. 2015;45:675-7.
    PubMed     Text format    


  442. LATTANZI S, Luzzi S, Provinciali L, Silvestrini M, et al
    Blood pressure variability in Alzheimer's disease and frontotemporal dementia: the effect on the rate of cognitive decline.
    J Alzheimers Dis. 2015;45:387-94.
    PubMed     Text format     Abstract available



  443. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;45:981-4.
    PubMed     Text format    



  444. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;45:1271-3.
    PubMed     Text format    


  445. SHAKESPEARE TJ, Yong KX, Foxe D, Hodges J, et al
    Pronounced impairment of everyday skills and self-care in posterior cortical atrophy.
    J Alzheimers Dis. 2015;43:381-4.
    PubMed     Text format     Abstract available


  446. MADERNA E, Cattaneo C, Cacciatore F, Catania M, et al
    Divergent cognitive status with the same Braak stage of neurofibrillary pathology: does the pattern of amyloid-beta deposits make the difference?
    J Alzheimers Dis. 2015;43:375-9.
    PubMed     Text format     Abstract available


  447. TUCKER S, Moller C, Tegerstedt K, Lord A, et al
    The murine version of BAN2401 (mAb158) selectively reduces amyloid-beta protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice.
    J Alzheimers Dis. 2015;43:575-88.
    PubMed     Text format     Abstract available


  448. SANTANGELO R, Coppi E, Ferrari L, Bernasconi MP, et al
    Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia.
    J Alzheimers Dis. 2015;43:1429-40.
    PubMed     Text format     Abstract available


  449. HAGHIGHI M, Smith A, Morgan D, Small B, et al
    Identifying cost-effective predictive rules of amyloid-beta level by integrating neuropsychological tests and plasma-based markers.
    J Alzheimers Dis. 2015;43:1261-70.
    PubMed     Text format     Abstract available


  450. ASO E, Sanchez-Pla A, Vegas-Lozano E, Maldonado R, et al
    Cannabis-based medicine reduces multiple pathological processes in AbetaPP/PS1 mice.
    J Alzheimers Dis. 2015;43:977-91.
    PubMed     Text format     Abstract available


  451. GIFFORD KA, Liu D, Damon SM, Chapman WG 4th, et al
    Subjective memory complaint only relates to verbal episodic memory performance in mild cognitive impairment.
    J Alzheimers Dis. 2015;44:309-18.
    PubMed     Text format     Abstract available


  452. KAWADA H, Blessing K, Kiyota T, Woolman T, et al
    Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-beta metal dyshomeostasis.
    J Alzheimers Dis. 2015;44:297-307.
    PubMed     Text format     Abstract available


  453. JOCHEMSEN HM, van der Flier WM, Ashby EL, Teunissen CE, et al
    Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy.
    J Alzheimers Dis. 2015;44:153-62.
    PubMed     Text format     Abstract available


  454. ECKERSTROM C, Olsson E, Klasson N, Berge J, et al
    Multimodal prediction of dementia with up to 10 years follow up: the Gothenburg MCI study.
    J Alzheimers Dis. 2015;44:205-14.
    PubMed     Text format     Abstract available


  455. SIECZKOWSKI E, Milenkovic I, Venkataramani V, Giera R, et al
    I716F AbetaPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-beta and alpha-synucleinopathy with Lewy bodies.
    J Alzheimers Dis. 2015;44:103-14.
    PubMed     Text format     Abstract available


  456. ROBB E, Perez K, Hung LW, Masters CL, et al
    High order W02-reactive stable oligomers of amyloid-beta are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-beta monomer.
    J Alzheimers Dis. 2015;44:69-78.
    PubMed     Text format     Abstract available


  457. MERRIL CR, Ghanbari HA
    Two hundred issues later: the dream comes true.
    J Alzheimers Dis. 2015;44:727-8.
    PubMed     Text format    


  458. PERRY G
    Two hundred treasured issues!
    J Alzheimers Dis. 2015;44:725.
    PubMed     Text format    


  459. BARRETT JP, Minogue AM, Jones RS, Ribeiro C, et al
    Bone marrow-derived macrophages from AbetaPP/PS1 mice are sensitized to the effects of inflammatory stimuli.
    J Alzheimers Dis. 2015;44:949-62.
    PubMed     Text format     Abstract available


  460. KIM HJ, Im K, Kwon H, Lee JM, et al
    Effects of amyloid and small vessel disease on white matter network disruption.
    J Alzheimers Dis. 2015;44:963-75.
    PubMed     Text format     Abstract available


  461. PUIG KL, Lutz BM, Urquhart SA, Rebel AA, et al
    Overexpression of mutant amyloid-beta protein precursor and presenilin 1 modulates enteric nervous system.
    J Alzheimers Dis. 2015;44:1263-78.
    PubMed     Text format     Abstract available


  462. ORDONEZ-GUTIERREZ L, Anton M, Wandosell F
    Peripheral amyloid levels present gender differences associated with aging in AbetaPP/PS1 mice.
    J Alzheimers Dis. 2015;44:1063-8.
    PubMed     Text format     Abstract available


  463. KOAL T, Klavins K, Seppi D, Kemmler G, et al
    Sphingomyelin SM(d18:1/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-beta42, tau, and phospho-tau-181 levels.
    J Alzheimers Dis. 2015;44:1193-201.
    PubMed     Text format     Abstract available


  464. LUNA-MUNOZ J, Perry G, Guevara J
    Raul Mena: 1953-2014.
    J Alzheimers Dis. 2015;45:325-7.
    PubMed     Text format    


  465. ITO K, Fukuyama H, Senda M, Ishii K, et al
    Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter Study.
    J Alzheimers Dis. 2015;45:543-52.
    PubMed     Text format     Abstract available


  466. MEISSNER JN, Bouter Y, Bayer TA
    Neuron Loss and Behavioral Deficits in the TBA42 Mouse Model Expressing N-Truncated Pyroglutamate Amyloid-beta3-42.
    J Alzheimers Dis. 2015;45:471-82.
    PubMed     Text format     Abstract available


  467. STRUYFS H, Van Broeck B, Timmers M, Fransen E, et al
    Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-beta Isoforms for Early and Differential Dementia Diagnosis.
    J Alzheimers Dis. 2015;45:813-22.
    PubMed     Text format     Abstract available


  468. PENG L, Yu Y, Liu J, Li S, et al
    The chemerin receptor CMKLR1 is a functional receptor for amyloid-beta peptide.
    J Alzheimers Dis. 2015;43:227-42.
    PubMed     Text format     Abstract available


  469. UHM KO, Kim MJ, Kawaguchi M, Akatsu H, et al
    ATBF1 is a novel amyloid-beta protein precursor (AbetaPP) binding protein that affects AbetaPP expression.
    J Alzheimers Dis. 2015;43:243-57.
    PubMed     Text format     Abstract available


  470. LI JG, Pratico D
    High levels of homocysteine results in cerebral amyloid angiopathy in mice.
    J Alzheimers Dis. 2015;43:29-35.
    PubMed     Text format     Abstract available


  471. GOZES I, Yeheskel A, Pasmanik-Chor M
    Activity-dependent neuroprotective protein (ADNP): a case study for highly conserved chordata-specific genes shaping the brain and mutated in cancer.
    J Alzheimers Dis. 2015;45:57-73.
    PubMed     Text format     Abstract available


  472. SUN Y, Bresell A, Rantalainen M, Hoglund K, et al
    An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Abeta1-42 Ratio in ApoE4-Negative Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2015;45:1061-76.
    PubMed     Text format     Abstract available


  473. NIEMANTSVERDRIET E, Feyen BF, Le Bastard N, Martin JJ, et al
    Overdiagnosing Vascular Dementia using Structural Brain Imaging for Dementia Work-Up.
    J Alzheimers Dis. 2015;45:1039-43.
    PubMed     Text format     Abstract available


    December 2014
  474. WISCHIK CM, Staff RT, Wischik DJ, Bentham P, et al
    Tau Aggregation Inhibitor Therapy: An Exploratory Phase 2 Study in Mild or Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  475. SILVERI MC, Ferrante I, Brita AC, Rossi P, et al
    "The Memory of Beauty" Survives Alzheimer's Disease (but Cannot Help Memory).
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  476. LACHNO DR, Evert BA, Maloney K, Willis BA, et al
    Validation and Clinical Utility of ELISA Methods for Quantification of Amyloid-beta Peptides in Cerebrospinal Fluid Specimens from Alzheimer's Disease Studies.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  477. ARMAND-UGON M, Aso E, Moreno J, Riera-Codina M, et al
    Memory Improvement in the AbetaPP/PS1 Mouse Model of Familial Alzheimer's Disease Induced by Carbamylated-Erythropoietin is Accompanied by Modulation of Synaptic Genes.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  478. JONGBLOED W, Bruggink KA, Kester MI, Visser P, et al
    Amyloid-beta Oligomers Relate to Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  479. PAMPHLETT R, Kum Jew S
    Different Populations of Human Locus Ceruleus Neurons Contain Heavy Metals or Hyperphosphorylated Tau: Implications for Amyloid-beta and Tau Pathology in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  480. MUNIZ R, Serra CM, Reisberg B, Rojo JM, et al
    Cognitive-Motor Intervention in Alzheimer's Disease: Long-Term Results from the Maria Wolff Trial.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  481. NISHIOKA C, Poh C, Sun S
    Diffusion Tensor Imaging Reveals Visual Pathway Damage in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  482. LOVESTONE S, Boada M, Dubois B, Hull M, et al
    A Phase II Trial of Tideglusib in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  483. WILKINS HM, Carl SM, Weber SG, Ramanujan SA, et al
    Mitochondrial Lysates Induce Inflammation and Alzheimer's Disease-Relevant Changes in Microglial and Neuronal Cells.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  484. BONCORAGLIO GB, Piazza F, Savoiardo M, Farina L, et al
    Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Abeta Autoantibodies.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  485. BUN S, Ikejima C, Kida J, Yoshimura A, et al
    A Combination of Supplements May Reduce the Risk of Alzheimer's Disease in Elderly Japanese with Normal Cognition.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  486. SUSANTO TA, Pua EP, Zhou J
    Cognition, Brain Atrophy, and Cerebrospinal Fluid Biomarkers Changes from Preclinical to Dementia Stage of Alzheimer's Disease and the Influence of Apolipoprotein E.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  487. SUN Y, Rong X, Lu W, Peng Y, et al
    Translational Study of Alzheimer's Disease (AD) Biomarkers from Brain Tissues in AbetaPP/PS1 Mice and Serum of AD Patients.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  488. MONACELLI F, Borghi R, Cammarata S, Nencioni A, et al
    Amnestic Mild Cognitive Impairment and Conversion to Alzheimer's Disease: Insulin Resistance and Glycoxidation as Early Biomarker Clusters.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  489. SENA CM, Pereira AM, Carvalho C, Fernandes R, et al
    Type 2 Diabetes Aggravates Alzheimer's Disease-Associated Vascular Alterations of the Aorta in Mice.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


    November 2014
  490. JINGAMI N, Uemura K, Noto R, Asada M, et al
    Idiopathic Normal Pressure Hydrocephalus has a Different Cerebrospinal Fluid Biomarker Profile from Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  491. CHEUNG CY, Ong YT, Hilal S, Ikram MK, et al
    Retinal Ganglion Cell Analysis Using High-Definition Optical Coherence Tomography in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  492. OLAH Z, Kalman J, Toth ME, Zvara A, et al
    Proteomic Analysis of Cerebrospinal Fluid in Alzheimer's Disease: Wanted Dead or Alive.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  493. KETTUNEN P, Larsson S, Holmgren S, Olsson S, et al
    Genetic Variants of GSK3B are Associated with Biomarkers for Alzheimer's Disease and Cognitive Function.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  494. NOLAN JM, Loskutova E, Howard A, Mulcahy R, et al
    The Impact of Supplemental Macular Carotenoids in Alzheimer's Disease: A Randomized Clinical Trial.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  495. SALZA R, Oudart JB, Ramont L, Maquart FX, et al
    Endostatin Level in Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  496. RYAN NS, Lashley T, Revesz T, Dantu K, et al
    Spontaneous ARIA (Amyloid-Related Imaging Abnormalities) and Cerebral Amyloid Angiopathy Related Inflammation in Presenilin 1-Associated Familial Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  497. HUTTENRAUCH M, Baches S, Gerth J, Bayer TA, et al
    Neprilysin Deficiency Alters the Neuropathological and Behavioral Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  498. BULATI M, Buffa S, Martorana A, Gervasi F, et al
    Double Negative (IgG+IgD-CD27-) B Cells are Increased in a Cohort of Moderate-Severe Alzheimer's Disease Patients and Show a Pro-Inflammatory Trafficking Receptor Phenotype.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  499. LANE RM, Darreh-Shori T
    Understanding the Beneficial and Detrimental Effects of Donepezil and Rivastigmine to Improve their Therapeutic Value.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  500. WILLIAMS PT
    Lower Risk of Alzheimer's Disease Mortality with Exercise, Statin, and Fruit Intake.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  501. WATT AD, Perez KA, Ang CS, O'Donnell P, et al
    Peripheral alpha-Defensins 1 and 2 are Elevated in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  502. SEEBURGER JL, Holder DJ, Combrinck M, Joachim C, et al
    Cerebrospinal Fluid Biomarkers Distinguish Postmortem-Confirmed Alzheimer's Disease from Other Dementias and Healthy Controls in the OPTIMA Cohort.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  503. KIM YJ, Cho H, Kim YJ, Ki CS, et al
    Apolipoprotein E4 Affects Topographical Changes in Hippocampal and Cortical Atrophy in Alzheimer's Disease Dementia: A Five-Year Longitudinal Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  504. CHAUDHRY M, Wang X, Bamne MN, Hasnain S, et al
    Genetic Variation in Imprinted Genes is Associated with Risk of Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  505. WUCHERER D, Eichler T, Kilimann I, Hertel J, et al
    Antidementia Drug Treatment in People Screened Positive for Dementia in Primary Care.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  506. DI DOMENICO F, Pupo G, Mancuso C, Barone E, et al
    Bach1 Overexpression in Down Syndrome Correlates with the Alteration of the HO-1/BVR-A System: Insights for Transition to Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  507. INGENBLEEK Y, Bernstein LH
    Downsizing of Lean Body Mass is a Key Determinant of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  508. JANG JW, Park SY, Park YH, Baek MJ, et al
    A Comprehensive Visual Rating Scale of Brain Magnetic Resonance Imagine: Application in Elderly Subjects with Alzheimer's Disease, Mild Cognitive Impairment, and Normal Cognition.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  509. HUMPHRIES CE, Kohli MA, Nathanson L, Whitehead P, et al
    Integrated Whole Transcriptome and DNA Methylation Analysis Identifies Gene Networks Specific to Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  510. KHAN TK, Alkon DL
    Peripheral Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  511. DAUPHINOT V, Delphin-Combe F, Mouchoux C, Dorey A, et al
    Risk Factors of Caregiver Burden Among Patients with Alzheimer's Disease or Related Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  512. HASCUP KN, Hascup ER
    Altered Neurotransmission Prior to Cognitive Decline in AbetaPP/PS1 Mice, a Model of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  513. HAWKINS KM, Goyal AI, Sergio LE
    Diffusion Tensor Imaging Correlates of Cognitive-Motor Decline in Normal Aging and Increased Alzheimer's Disease Risk.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  514. CLAXTON A, Baker LD, Hanson A, Trittschuh EH, et al
    Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


    October 2014
  515. MORBELLI S, Brugnolo A, Bossert I, Buschiazzo A, et al
    Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  516. FOLEY AM, Ammar ZM, Lee RH, Mitchell CS, et al
    Systematic Review of the Relationship between Amyloid-beta Levels and Measures of Transgenic Mouse Cognitive Deficit in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  517. AL-KHATEEB E, Althaher A, Al-Khateeb M, Al-Musawi H, et al
    Relation between Uric Acid and Alzheimer's Disease in Elderly Jordanians.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  518. GRAHAM SF, Nasarauddin MB, Carey M, McGuinness B, et al
    Quantitative Measurement of [Na+] and [K+] in Postmortem Human Brain Tissue Indicates Disturbances in Subjects with Alzheimer's Disease and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  519. MARCHANT NL, Howard RJ
    Cognitive Debt and Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  520. ACQUAAH-MENSAH GK, Agu N, Khan T, Gardner A, et al
    A Regulatory Role for the Insulin- and BDNF-Linked RORA in the Hippocampus: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  521. RANGARAJU S, Gearing M, Jin LW, Levey A, et al
    Potassium Channel Kv1.3 Is Highly Expressed by Microglia in Human Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  522. YU J, Luo X, Xu H, Ma Q, et al
    Identification of the Key Molecules Involved in Chronic Copper Exposure-Aggravated Memory Impairment in Transgenic Mice of Alzheimer's Disease Using Proteomic Analysis.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  523. MATSUMURA A, Suzuki S, Iwahara N, Hisahara S, et al
    Temporal Changes of CD68 and alpha7 Nicotinic Acetylcholine Receptor Expression in Microglia in Alzheimer's Disease-Like Mouse Models.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  524. TEUNISSEN CE, van der Flier WM, Scheltens P, Duits A, et al
    Serum Leptin is not Altered nor Related to Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  525. MANGIALASCHE F, Baglioni M, Cecchetti R, Kivipelto M, et al
    Lymphocytic Mitochondrial Aconitase Activity is Reduced in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  526. PARK HK, Choi SH, Park SA, Kim HJ, et al
    Cognitive Profiles and Neuropsychiatric Symptoms in Korean Early-Onset Alzheimer's Disease Patients: A CREDOS Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  527. MOLLER C, Dieleman N, van der Flier WM, Versteeg A, et al
    More Atrophy of Deep Gray Matter Structures in Frontotemporal Dementia Compared to Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  528. OLDE RIKKERT MG, Verhey FR, Blesa R, von Arnim CA, et al
    Tolerability and Safety of Souvenaid in Patients with Mild Alzheimer's Disease: Results of Multi-Center, 24-Week, Open-Label Extension Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  529. STONE J, Johnstone DM, Mitrofanis J, O'Rourke M, et al
    The Mechanical Cause of Age-Related Dementia (Alzheimer's Disease): The Brain is Destroyed by the Pulse.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  530. TANG X, Holland D, Dale AM, Younes L, et al
    Baseline Shape Diffeomorphometry Patterns of Subcortical and Ventricular Structures in Predicting Conversion of Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  531. WALKER JM, Klakotskaia D, Ajit D, Weisman GA, et al
    Beneficial Effects of Dietary EGCG and Voluntary Exercise on Behavior in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  532. BARUCKER C, Sommer A, Beckmann G, Eravci M, et al
    Alzheimer Amyloid Peptide Abeta42 Regulates Gene Expression of Transcription and Growth Factors.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  533. BOWEN RL, Perry G, Xiong C, Smith MA, et al
    A Clinical Study of Lupron Depot in the Treatment of Women with Alzheimer's Disease: Preservation of Cognitive Function in Patients Taking an Acetylcholinesterase Inhibitor and Treated with High Dose Lupron Over 48 Weeks.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  534. JUNG CR, Lin YT, Hwang BF
    Ozone, Particulate Matter, and Newly Diagnosed Alzheimer's Disease: A Population-Based Cohort Study in Taiwan.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  535. MEUNIER J, Borjini N, Gillis C, Villard V, et al
    Brain Toxicity and Inflammation Induced In Vivo in Mice by the Amyloid-beta Forty-Two Inducer Aftin-4, a Roscovitine Derivative.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  536. TOMEK A, Urbanova B, Hort J
    Utility of Transcranial Ultrasound in Predicting Alzheimer's Disease Risk.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  537. RUELI RH, Parubrub AC, Dewing AS, Hashimoto AC, et al
    Increased Selenoprotein P in Choroid Plexus and Cerebrospinal Fluid in Alzheimer's Disease Brain.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


    September 2014
  538. MORTAMAIS M, Sylvaine A, Ritchie K
    White Matter Hyperintensities as Early and Independent Predictors of Alzheimer's Disease Risk.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  539. MOHAMED NE, Lee JH, Francis PT, Esiri MM, et al
    Differential Alterations of Neocortical GluN Receptor Subunits in Patients with Mixed Subcortical Ischemic Vascular Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  540. ZHANG C, Rissman RA, Feng J
    Characterization of ATP Alternations in an Alzheimer's Disease Transgenic Mouse Model.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  541. PAL A, Siotto M, Prasad R, Squitti R, et al
    Towards a Unified Vision of Copper Involvement in Alzheimer's Disease: A Review Connecting Basic, Experimental, and Clinical Research.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  542. STOTHART G, Kazanina N, Naatanen R, Haworth J, et al
    Early Visual Evoked Potentials and Mismatch Negativity in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  543. WOODWARD MC, Rowe CC, Jones G, Villemagne VL, et al
    Differentiating the Frontal Presentation of Alzheimer's Disease with FDG-PET.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  544. POLIDORI MC
    Preventive Benefits of Natural Nutrition and Lifestyle Counseling against Alzheimer's Disease Onset.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  545. MCCLURE R, Yanagisawa D, Stec D, Abdollahian D, et al
    Inhalable Curcumin: Offering the Potential for Translation to Imaging and Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  546. WANG J, Tan L, Wang HF, Tan CC, et al
    Anti-Inflammatory Drugs and Risk of Alzheimer's Disease: An Updated Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  547. THAL DR, Attems J, Ewers M
    Spreading of Amyloid, Tau, and Microvascular Pathology in Alzheimer's Disease: Findings from Neuropathological and Neuroimaging Studies.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  548. KHUNDAKAR AA, Thomas AJ
    Neuropathology of Depression in Alzheimer's Disease: Current Knowledge and the Potential for New Treatments.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  549. JI L, Zhao X, Hua Z
    Potential Therapeutic Implications of Gelsolin in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  550. ZHU XC, Yu Y, Wang HF, Jiang T, et al
    Physiotherapy Intervention in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  551. GIRONI M, Borgiani B, Farina E, Mariani E, et al
    A Global Immune Deficit in Alzheimer's Disease and Mild Cognitive Impairment Disclosed by a Novel Data Mining Process.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  552. HALL A, Munoz-Ruiz M, Mattila J, Koikkalainen J, et al
    Generalizability of the Disease State Index Prediction Model for Identifying Patients Progressing from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  553. BOZZALI M, Dowling C, Serra L, Spano B, et al
    The Impact of Cognitive Reserve on Brain Functional Connectivity in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  554. SUPPA P, Anker U, Spies L, Bopp I, et al
    Fully Automated Atlas-Based Hippocampal Volumetry for Detection of Alzheimer's Disease in a Memory Clinic Setting.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  555. CHANG KL, Pee HN, Tan WP, Dawe GS, et al
    Metabolic Profiling of CHO-AbetaPP695 Cells Revealed Mitochondrial Dysfunction Prior to Amyloid-beta Pathology and Potential Therapeutic Effects of Both PPARgamma and PPARalpha Agonisms for Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  556. GOH LK, Lim WS, Teo S, Vijayaraghavan A, et al
    TOMM40 Alterations in Alzheimer's Disease Over a 2-Year Follow-Up Period.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  557. BELLEVILLE S, Fouquet C, Duchesne S, Collins DL, et al
    Detecting Early Preclinical Alzheimer's Disease via Cognition, Neuropsychiatry, and Neuroimaging: Qualitative Review and Recommendations for Testing.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  558. DITACCHIO KA, Heinemann SF, Dziewczapolski G
    Metformin Treatment Alters Memory Function in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  559. MONTEIRO-CARDOSO VF, Oliveira MM, Melo T, Domingues MR, et al
    Cardiolipin Profile Changes are Associated to the Early Synaptic Mitochondrial Dysfunction in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  560. WANG Z
    Characterizing Early Alzheimer's Disease and Disease Progression Using Hippocampal Volume and Arterial Spin Labeling Perfusion MRI.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  561. WANG HF, Tan L, Hao XK, Jiang T, et al
    Effect of EPHA1 Genetic Variation on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  562. MOLITOR RJ, Ko PC, Ally BA
    Eye Movements in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  563. THORDARDOTTIR S, Stahlbom AK, Ferreira D, Almkvist O, et al
    Preclinical Cerebrospinal Fluid and Volumetric Magnetic Resonance Imaging Biomarkers in Swedish Familial Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  564. MAHESHWARI P, Eslick GD
    Bacterial Infection and Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


    August 2014
  565. HENRIKSEN K, Byrjalsen I, Christiansen C, Karsdal MA, et al
    Relationship between Serum Levels of Tau Fragments and Clinical Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  566. GATES NJ, Sachdev P
    Is Cognitive Training an Effective Treatment for Preclinical and Early Alzheimer's Disease?
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  567. GOUGH M, Blanthorn-Hazell S, Parkin ET
    The Histidine Composition of the Amyloid-beta Domain, but not the E1 Copper Binding Domain, Modulates beta-Secretase Processing of Amyloid-beta Protein Precursor in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  568. LAN YL, Zhao J, Li S
    Update on the Neuroprotective Effect of Estrogen Receptor Alpha Against Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  569. TAKIZAWA C, Thompson PL, van Walsem A, Faure C, et al
    Epidemiological and Economic Burden of Alzheimer's Disease: A Systematic Literature Review of Data across Europe and the United States of America.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  570. BAJIC V, Mandusic V, Stefanova E, Bozovic A, et al
    Skewed X-Chromosome Inactivation in Women Affected by Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  571. WIERENGA CE, Hays CC, Zlatar ZZ
    Cerebral Blood Flow Measured by Arterial Spin Labeling MRI as a Preclinical Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  572. PENA-LONGOBARDO LM, Oliva-Moreno J
    Caregiver Burden in Alzheimer's Disease Patients in Spain.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  573. PIACERI I, Raspanti B, Tedde A, Bagnoli S, et al
    Epigenetic Modifications in Alzheimer's Disease: Cause or Effect?
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  574. MROCZKO B, Groblewska M, Zboch M, Muszynski P, et al
    Evaluation of Visinin-Like Protein 1 Concentrations in the Cerebrospinal Fluid of Patients with Mild Cognitive Impairment as a Dynamic Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  575. MUENCHHOFF J, Poljak A, Song F, Raftery M, et al
    Plasma Protein Profiling of Mild Cognitive Impairment and Alzheimer's Disease Across Two Independent Cohorts.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  576. BEDSE G, Romano A, Lavecchia AM, Cassano T, et al
    The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  577. SCHEFF SW, Price DA, Ansari MA, Roberts KN, et al
    Synaptic Change in the Posterior Cingulate Gyrus in the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  578. VICARIO-ORRI E, Opazo C, Munoz FJ
    The Pathophysiology of Axonal Transport in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  579. DIAZ M, Fabelo N, Ferrer I, Gomez T, et al
    Biophysical Alterations in Lipid Rafts from Human Cerebral Cortex Associate with Increased BACE1/AbetaPP Interaction in Early Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  580. EMMERZAAL TL, Kiliaan AJ, Gustafson DR
    2003-2013: A Decade of Body Mass Index, Alzheimer's Disease, and Dementia.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  581. FERREIRA D, Westman E, Eyjolfsdottir H, Almqvist P, et al
    Brain Changes in Alzheimer's Disease Patients with Implanted Encapsulated Cells Releasing Nerve Growth Factor.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  582. CASTELLANO CA, Nugent S, Paquet N, Tremblay S, et al
    Lower Brain 18F-Fluorodeoxyglucose Uptake But Normal 11C-Acetoacetate Metabolism in Mild Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  583. GALLEGO-JUTGLA E, Sole-Casals J, Vialatte FB, Dauwels J, et al
    A Theta-Band EEG Based Index for Early Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  584. BONOTI F, Tzouvaleka E, Bonotis K, Vlachos F, et al
    Do Patients with Alzheimer's Disease Draw like Young Children? An Exploratory Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  585. KHAN TK, Sen A, Hongpaisan J, Lim CS, et al
    PKCepsilon Deficits in Alzheimer's Disease Brains and Skin Fibroblasts.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  586. ZHAO H, Li H, Ruberu K, Garner B, et al
    Impaired Lysosomal Cobalamin Transport in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  587. SAAD Y, Segal D, Ayali A
    Enhanced Neurite Outgrowth and Branching Precede Increased Amyloid-beta-Induced Neuronal Apoptosis in a Novel Alzheimer's Disease Model.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  588. HAGL S, Grewal R, Ciobanu I, Helal A, et al
    Rice Bran Extract Compensates Mitochondrial Dysfunction in a Cellular Model of Early Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  589. PISA D, Alonso R, Juarranz A, Rabano A, et al
    Direct Visualization of Fungal Infection in Brains from Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  590. SHOEMARK DK, Allen SJ
    The Microbiome and Disease: Reviewing the Links between the Oral Microbiome, Aging, and Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  591. DUNN HC, Ager RR, Baglietto-Vargas D, Cheng D, et al
    Restoration of Lipoxin A4 Signaling Reduces Alzheimer's Disease-Like Pathology in the 3xTg-AD Mouse Model.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  592. DEKKER AD, Coppus AM, Vermeiren Y, Aerts T, et al
    Serum MHPG Strongly Predicts Conversion to Alzheimer's Disease in Behaviorally Characterized Subjects with Down Syndrome.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  593. SCHMIDT C, Gerlach N, Peter C, Gherib K, et al
    Cerebrospinal Fluid Apolipoprotein E Concentration and Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  594. FU Y, Hsiao JH, Paxinos G, Halliday GM, et al
    ABCA5 Regulates Amyloid-beta Peptide Production and is Associated with Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  595. MACKIN RS, Insel P, Zhang J, Mohlenhoff B, et al
    Cerebrospinal Fluid alpha-Synuclein and Lewy Body-Like Symptoms in Normal Controls, Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  596. GROSSI D, de Lucia N, Trojano L
    Closing-in is related to Apathy in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  597. SOUSA MF, Santos RL, Nogueira ML, Belfort T, et al
    Awareness of Disease is Different for Cognitive and Functional Aspects in Mild Alzheimer's Disease: A One-Year Observation Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  598. DELONCLE R, Guillard O
    Is Brain Copper Deficiency in Alzheimer's, Lewy Body, and Creutzfeldt Jakob Diseases the Common Key for a Free Radical Mechanism and Oxidative Stress-Induced Damage?
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  599. GLODZIK L, Sollberger M, Gass A, Gokhale A, et al
    Global N-Acetylaspartate in Normal Subjects, Mild Cognitive Impairment and Alzheimer's Disease Patients.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  600. LIU-SEIFERT H, Siemers E, Sundell K, Price K, et al
    Cognitive and Functional Decline and Their Relationship in Patients with Mild Alzheimer's Dementia.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  601. DE LA TORRE JC
    In-House Heart-Brain Clinics to Reduce Alzheimer's Disease Incidence.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  602. LUCKE-WOLD BP, Turner RC, Logsdon AF, Simpkins JW, et al
    Common Mechanisms of Alzheimer's Disease and Ischemic Stroke: The Role of Protein Kinase C in the Progression of Age-Related Neurodegeneration.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  603. HAMPSTEAD BM, Mosti CB, Swirsky-Sacchetti T
    Cognitively-Based Methods of Enhancing and Maintaining Functioning in those at Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  604. ANSTEY KJ, Eramudugolla R, Dixon RA
    Contributions of a Risk Assessment Approach to the Prevention of Alzheimer's Disease and Dementia.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  605. SERPENTE M, Fenoglio C, Clerici F, Bonsi R, et al
    Transmembrane Protein 106B Gene (TMEM106B) Variability and Influence on Progranulin Plasma Levels in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  606. MCNEELY AA, Ramirez J, Nestor SM, Zhao J, et al
    Cholinergic Subcortical Hyperintensities in Alzheimer's Disease Patients from the Sunnybrook Dementia Study: Relationships with Cognitive Dysfunction and Hippocampal Atrophy.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  607. DU LL, Chai DM, Zhao LN, Li XH, et al
    AMPK Activation Ameliorates Alzheimer's Disease-Like Pathology and Spatial Memory Impairment in a Streptozotocin-Induced Alzheimer's Disease Model in Rats.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  608. LI JC, Han L, Wen YX, Yang YX, et al
    Increased Permeability of the Blood-Brain Barrier and Alzheimer's Disease-Like Alterations in Slit-2 Transgenic Mice.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  609. ZHAO X, Lejnine S, Spond J, Zhang C, et al
    A Candidate Plasma Protein Classifier to Identify Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  610. IVANOIU A, Dricot L, Gilis N, Grandin C, et al
    Classification of Non-Demented Patients Attending a Memory Clinic using the New Diagnostic Criteria for Alzheimer's Disease with Disease-Related Biomarkers.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  611. SONG H, Chang YJ, Moon M, Park SK, et al
    Inhibition of Glutaminyl Cyclase Ameliorates Amyloid Pathology in an Animal Model of Alzheimer's Disease via the Modulation of gamma-Secretase Activity.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  612. WANG X, Lopez OL, Sweet RA, Becker JT, et al
    Genetic Determinants of Disease Progression in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  613. KUMAR P, Jha NK, Jha SK, Ramani K, et al
    Tau Phosphorylation, Molecular Chaperones, and Ubiquitin E3 Ligase: Clinical Relevance in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  614. WANG Y, Wu L, Fang D, Zhong C, et al
    Synergistic Exacerbation of Mitochondrial and Synaptic Dysfunction and Resultant Learning and Memory Deficit in a Mouse Model of Diabetic Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  615. ZHOU J, Yu JT, Wang HF, Meng XF, et al
    Association between Stroke and Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  616. SIMIELI L, Barbieri FA, Orcioli-Silva D, Lirani-Silva E, et al
    Obstacle Crossing with Dual Tasking is a Danger for Individuals with Alzheimer's Disease and for Healthy Older People.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  617. BENKE T, Sanin G, Lechner A, Dal-Bianco P, et al
    Predictors of Patient Dependence in Mild-to-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  618. RAMIREZ J, Berezuk C, McNeely AA, Scott CJ, et al
    Visible Virchow-Robin Spaces on Magnetic Resonance Imaging of Alzheimer's Disease Patients and Normal Elderly from the Sunnybrook Dementia Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  619. CHIAM JT, Dobson RJ, Kiddle SJ, Sattlecker M, et al
    Are Blood-Based Protein Biomarkers for Alzheimer's Disease also Involved in Other Brain Disorders? A Systematic Review.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  620. MARTISKAINEN H, Helisalmi S, Viswanathan J, Kurki M, et al
    Effects of Alzheimer's Disease-Associated Risk Loci on Cerebrospinal Fluid Biomarkers and Disease Progression: A Polygenic Risk Score Approach.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  621. ZENG F, Xie WT, Wang YJ, Luo HB, et al
    General Public Perceptions and Attitudes toward Alzheimer's Disease from Five Cities in China.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


    July 2014
  622. GRAMMAS P, Martinez JM
    Targeting Thrombin: An Inflammatory Neurotoxin in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  623. VILLARS H, Dupuy C, Perrin A, Vellas B, et al
    Impact of a Therapeutic Educational Program on Quality of Life in Alzheimer's Disease: Results of a Pilot Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  624. LEWCZUK P, Lelental N, Spitzer P, Maler JM, et al
    Amyloid-beta 42/40 Cerebrospinal Fluid Concentration Ratio in the Diagnostics of Alzheimer's Disease: Validation of Two Novel Assays.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  625. RAFII MS
    Preclinical Alzheimer's Disease Therapeutics.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  626. MONTERO-ODASSO M, Muir-Hunter SW, Oteng-Amoako A, Gopaul K, et al
    Donepezil Improves Gait Performance in Older Adults with Mild Alzheimer's Disease: A Phase II Clinical Trial.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  627. ANDRADE DE OLIVEIRA A, Carthery-Goulart MT, Oliveira Junior PP, Carrettiero DC, et al
    Defining Multivariate Normative Rules for Healthy Aging using Neuroimaging and Machine Learning: An Application to Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  628. BALSIS S, Lowe DA
    A Fresh Perspective Revealed by Powerful Trends in Alzheimer's Disease Research.
    J Alzheimers Dis. 2014.
    PubMed     Text format    


  629. SEIFAN A, Marder KS, Mez J, Noble JM, et al
    Hippocampal Laminar Distribution of Tau Relates to Alzheimer's Disease and Age of Onset.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  630. XIU-LIAN W, Ji Z, Yang Y, Yan X, et al
    Helicobacter pylori Filtrate Induces Alzheimer-Like Tau Hyperphosphorylation by Activating Glycogen Synthase Kinase-3beta
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  631. NAUGHTON BJ, Duncan FJ, Murrey DA, Meadows AS, et al
    Blood Genome-Wide Transcriptional Profiles Reflect Broad Molecular Impairments and Strong Blood-Brain Links in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  632. BISHNOI RJ, Palmer RF, Royall DR
    Vitamin D Binding Protein as a Serum Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  633. YU D, Tao BB, Yang YY, Du LS, et al
    The IDO Inhibitor Coptisine Ameliorates Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  634. MATE I, Cruces J, Gimenez-Llort L, De la Fuente M, et al
    Function and Redox State of Peritoneal Leukocytes as Preclinical and Prodromic Markers in a Longitudinal Study of Triple-Transgenic Mice for Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  635. HRADEK AC, Lee HP, Siedlak SL, Torres SL, et al
    Distinct Chronology of Neuronal Cell Cycle Re-Entry and Tau Pathology in the 3xTg-AD Mouse Model and Alzheimer's Disease Patients.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  636. DE LA TORRE JC
    Detection, Prevention, and Pre-Clinical Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format    


  637. VERSIJPT J
    Effectiveness and Cost-Effectiveness of the Pharmacological Treatment of Alzheimer's Disease and Vascular Dementia.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  638. PEREZ DE LARA MJ, Pintor J
    Presence and Release of ATP from the Retina in an Alzheimer's Disease Model.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  639. PEREZ-GRIJALBA V, Pesini P, Allue JA, Sarasa L, et al
    Abeta1-17 is a Major Amyloid-beta Fragment Isoform in Cerebrospinal Fluid and Blood with Possible Diagnostic Value in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  640. RENTOUMI V, Raoufian L, Ahmed S, de Jager CA, et al
    Features and Machine Learning Classification of Connected Speech Samples from Patients with Autopsy Proven Alzheimer's Disease with and without Additional Vascular Pathology.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  641. RAHMAN T, Davies DS, Tannenberg RK, Fok S, et al
    Cofilin Rods and Aggregates Concur with Tau Pathology and the Development of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  642. PARCERISAS A, Rubio SE, Muhaisen A, Gomez-Ramos A, et al
    Somatic Signature of Brain-Specific Single Nucleotide Variations in Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  643. CHENG D, Spiro AS, Jenner AM, Garner B, et al
    Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  644. BITTNER DM, Wieseler I, Wilhelm H, Riepe MW, et al
    Repetitive Pupil Light Reflex: Potential Marker in Alzheimer's Disease?
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  645. O'BRYANT SE, Xiao G, Zhang F, Edwards M, et al
    Validation of a Serum Screen for Alzheimer's Disease Across Assay Platforms, Species, and Tissues.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  646. MUTHAIYAH B, Essa MM, Lee M, Chauhan V, et al
    Dietary Supplementation of Walnuts Improves Memory Deficits and Learning Skills in Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  647. GRAHAM SF, Nasaruddin MB, Carey M, Holscher C, et al
    Age-Associated Changes of Brain Copper, Iron, and Zinc in Alzheimer's Disease and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  648. MIURA Y, Miyaji K, Chai YL, Chen CL, et al
    Autoantibodies to GM1 and GQ1balpha are not Biological Markers of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  649. PESINI A, Iglesias E, Garrido N, Bayona-Bafaluy MP, et al
    OXPHOS, Pyrimidine Nucleotides, and Alzheimer's Disease: A Pharmacogenomics Approach.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  650. MENG XF, Yu JT, Wang HF, Tan MS, et al
    Midlife Vascular Risk Factors and the Risk of Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  651. ALVAREZ A, Aleixandre M, Linares C, Masliah E, et al
    Apathy and APOE4 are associated with Reduced BDNF Levels in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  652. COLUCCI L, Bosco M, Fasanaro AM, Gaeta GL, et al
    Alzheimer's Disease Costs: What We Know and What We Should Take into Account.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  653. GALIMBERTI D, Villa C, Fenoglio C, Serpente M, et al
    Circulating miRNAs as Potential Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  654. CHIRILA FV, Khan TK, Alkon DL
    Fibroblast Aggregation Rate Converges with Validated Peripheral Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  655. LIBON DJ, Drabick DA, Giovannetti T, Price CC, et al
    Neuropsychological Syndromes Associated with Alzheimer's/Vascular Dementia: A Latent Class Analysis.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  656. VAN DER MUSSELE S, Fransen E, Struyfs H, Luyckx J, et al
    Depression in Mild Cognitive Impairment is associated with Progression to Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  657. CAO C, Li Y, Liu H, Bai G, et al
    The Potential Therapeutic Effects of THC on Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  658. TAN CC, Yu JT, Tan L
    Biomarkers for Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  659. MONACELLI F, Rosa GM
    Cholinesterase Inhibitors: Cardioprotection in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  660. ANTONELL A, Mansilla A, Rami L, Llado A, et al
    Cerebrospinal Fluid Level of YKL-40 Protein in Preclinical and Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  661. XIA Y, Liu R, Chen R, Tian Q, et al
    Novel Multipotent AChEI-CCB Attenuates Hyperhomocysteinemia-Induced Memory Deficits and Neuropathologies in Rats.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  662. GODEFROY O, Martinaud O, Verny M, Mosca C, et al
    The Dysexecutive Syndrome of Alzheimer's Disease: The GREFEX Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  663. NOLAN JM, Loskutova E, Howard AN, Moran R, et al
    Macular Pigment, Visual Function, and Macular Disease among Subjects with Alzheimer's Disease: An Exploratory Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  664. HAIG GM, Pritchett Y, Meier A, Othman AA, et al
    A Randomized Study of H3 Antagonist ABT-288 in Mild-To-Moderate Alzheimer's Dementia.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  665. PORQUET D, Grinan-Ferre C, Ferrer I, Camins A, et al
    Neuroprotective Role of Trans-Resveratrol in a Murine Model of Familial Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  666. GUERINI FR, Agliardi C, Sironi M, Arosio B, et al
    Possible Association between SNAP-25 Single Nucleotide Polymorphisms and Alterations of Categorical Fluency and Functional MRI Parameters in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  667. SHEN XL, Yu JH, Zhang DF, Xie JX, et al
    Positive Relationship between Mortality from Alzheimer's Disease and Soil Metal Concentration in Mainland China.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  668. WILLIAMS MA, Silvestri V, Craig D, Passmore AP, et al
    The Prevalence of Age-Related Macular Degeneration in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  669. HOLLER CJ, Davis PR, Beckett TL, Platt TL, et al
    Bridging Integrator 1 (BIN1) Protein Expression Increases in the Alzheimer's Disease Brain and Correlates with Neurofibrillary Tangle Pathology.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  670. LAURSEN B, Mork A, Kristiansen U, Bastlund JF, et al
    Hippocampal P3-Like Auditory Event-Related Potentials are Disrupted in a Rat Model of Cholinergic Degeneration in Alzheimer's Disease: Reversal by Donepezil Treatment.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


    June 2014
  671. TONG Y, Yang H, Tian X, Wang H, et al
    High Manganese, A Risk for Alzheimer's Disease: High Manganese Induces Amyloid-beta Related Cognitive Impairment.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  672. LANZA C, Knorzer O, Weber M, Riepe MW, et al
    Autonomous Spatial Orientation in Patients with Mild to Moderate Alzheimer's Disease by using Mobile Assistive Devices: A Pilot Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  673. CHI S, Yu JT, Tan MS, Tan L, et al
    Depression in Alzheimer's Disease: Epidemiology, Mechanisms, and Management.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  674. SINGHRAO SK, Harding A, Simmons T, Robinson S, et al
    Oral Inflammation, Tooth Loss, Risk Factors, and Association with Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  675. BALOYANNIS SJ
    Golgi Apparatus and Protein Trafficking in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  676. MANUEL I, de San Roman EG, Giralt MT, Ferrer I, et al
    Type-1 Cannabinoid Receptor Activity During Alzheimer's Disease Progression.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  677. FREUND-LEVI Y, Vedin I, Hjorth E, Basun H, et al
    Effects of Supplementation with Omega-3 Fatty Acids on Oxidative Stress and Inflammation in Patients with Alzheimer's Disease: The OmegAD Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  678. VILLARREAL AE, Barron R, Rao KS, Britton GB, et al
    The Effects of Impaired Cerebral Circulation on Alzheimer's Disease Pathology: Evidence from Animal Studies.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  679. TRUJILLO-ESTRADA L, Davila JC, Sanchez-Mejias E, Sanchez-Varo R, et al
    Early Neuronal Loss and Axonal/Presynaptic Damage is Associated with Accelerated Amyloid-beta Accumulation in AbetaPP/PS1 Alzheimer's Disease Mice Subiculum.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  680. MATO ABAD V, Quiros A, Garcia-Alvarez R, Loureiro JP, et al
    The Partial Volume Effect in the Quantification of 1H Magnetic Resonance Spectroscopy in Alzheimer's Disease and Aging.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  681. MARTIN SB, Dowling AL, Lianekhammy J, Lott IT, et al
    Synaptophysin and Synaptojanin-1 in Down Syndrome are Differentially Affected by Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  682. FARIAS GA, Guzman-Martinez L, Delgado C, Maccioni RB, et al
    Nutraceuticals: A Novel Concept in Prevention and Treatment of Alzheimer's Disease and Related Disorders.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  683. DELABIO R, Rasmussen L, Mizumoto I, Viani GA, et al
    PSEN1 and PSEN2 Gene Expression in Alzheimer's Disease Brain: A New Approach.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  684. GUO H, Song X, Schmidt MH, Vandorpe R, et al
    Evaluation of Whole Brain Health in Aging and Alzheimer's Disease: A Standard Procedure for Scoring an MRI-Based Brain Atrophy and Lesion Index.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  685. PETER J, Abdulkadir A, Kaller C, Kummerer D, et al
    Subgroups of Alzheimer's Disease: Stability of Empirical Clusters Over Time.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  686. HAWKINS KM, Sergio LE
    Visuomotor Impairments in Older Adults at Increased Alzheimer's Disease Risk.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  687. CONDE-SALA JL, Turro-Garriga O, Calvo-Perxas L, Vilalta-Franch J, et al
    Three-Year Trajectories of Caregiver Burden in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  688. KAWAHARA K, Suenobu M, Ohtsuka H, Kuniyasu A, et al
    Cooperative Therapeutic Action of Retinoic Acid Receptor and Retinoid X Receptor Agonists in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  689. NAZCO CV, Perez LP, Molinuevo JL, Mar J, et al
    Cost-Effectiveness of the Use of Biomarkers in Cerebrospinal Fluid for Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  690. EDWARDS M, Balldin VH, Hall J, O'Bryant S, et al
    Combining Select Neuropsychological Assessment with Blood-Based Biomarkers to Detect Mild Alzheimer's Disease: A Molecular Neuropsychology Approach.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  691. TAO Y, Wang Y, Rogers JT, Wang F, et al
    Perturbed Iron Distribution in Alzheimer's Disease Serum, Cerebrospinal Fluid, and Selected Brain Regions: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  692. MA LL, Yu JT, Wang HF, Meng XF, et al
    Association between Cancer and Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  693. FROESTL W, Muhs A, Pfeifer A
    Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 2014.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  694. STOCKBURGER C, Gold VA, Pallas T, Kolesova N, et al
    A Cell Model for the Initial Phase of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  695. TIAN L, Zhang K, Tian ZY, Wang T, et al
    Decreased Expression of Cathepsin D in Monocytes is Related to the Defective Degradation of Amyloid-beta in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  696. IMTIAZ B, Tuppurainen M, Tiihonen M, Kivipelto M, et al
    Oophorectomy, Hysterectomy, and Risk of Alzheimer's Disease: A Nationwide Case-Control Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  697. KOUTSOURAKI E, Hatzifilippou E, Michmizos D, Banaki T, et al
    The Probable Auto-Antigenic Role of Lipids (Anti-Ganglioside Antibodies) in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  698. HARTMANN T, van Wijk N, Wurtman RJ, Olde Rikkert MG, et al
    A Nutritional Approach to Ameliorate Altered Phospholipid Metabolism in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  699. FEMMINELLA GD, Rengo G, Komici K, Iacotucci P, et al
    Autonomic Dysfunction in Alzheimer's Disease: Tools for Assessment and Review of the Literature.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  700. ISHIBASHI K, Miura Y, Oda K, Ishiwata K, et al
    Alzheimer's Disease-Like Pattern of 18F-FDG Uptake during a Hyperglycemic State and Negative 11C-PiB Binding in a Patient with Mild Cognitive Impairment.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  701. OOSTERVELD SM, Kessels RP, Hamel R, Ramakers IH, et al
    The Influence of Co-Morbidity and Frailty on the Clinical Manifestation of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  702. AMENTA F, Carotenuto A, Fasanaro AM, Rea R, et al
    The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: Interim Results after Two Years of Treatment.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  703. MACDONALD IR, Rockwood K, Martin E, Darvesh S, et al
    Cholinesterase Inhibition in Alzheimer's Disease: Is Specificity the Answer?
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  704. KIM E, Jung YS, Kim H, Kim JS, et al
    Metabolomic Signatures in Peripheral Blood Associated with Alzheimer's Disease Amyloid-beta-Induced Neuroinflammation.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


    May 2014
  705. OLAZARAN J, Gonzalez B, Osa-Ruiz E, Felipe-Ruiz S, et al
    Motor Effects of Radio Electric Asymmetric Conveyer in Alzheimer's Disease: Results from a Cross-Over Trial.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  706. ROY K, Pepin LC, Philiossaint M, Lorius N, et al
    Regional Fluorodeoxyglucose Metabolism and Instrumental Activities of Daily Living across the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  707. DESAI G, Zheng C, Geetha T, Mathews ST, et al
    The Pancreas-Brain Axis: Insight into Disrupted Mechanisms Associating Type 2 Diabetes and Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  708. AMADORO G, Corsetti V, Sancesario GM, Lubrano A, et al
    Cerebrospinal Fluid Levels of a 20-22 kDa NH2 Fragment of Human Tau Provide a Novel Neuronal Injury Biomarker in Alzheimer's Disease and Other Dementias.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  709. ZHANG L, Liu C, Wu J, Tao JJ, et al
    Tubastatin A/ACY-1215 Improves Cognition in Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  710. MAROOF N, Ravipati S, Pardon MC, Barrett DA, et al
    Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AbetaPPswe/PS1DeltaE9 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  711. GHOSH D, Brewer GJ
    External cys/cySS Redox State Modification Controls the Intracellular Redox State and Neurodegeneration via Akt in Aging and Alzheimer's Disease Mouse Model Neurons.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  712. MULLER U, Winter P, Bolender C, Nolte D, et al
    Previously Unrecognized Missense Mutation E126K of PSEN2 Segregates with Early Onset Alzheimer's Disease in a Family.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  713. MAYA-VETENCOURT JF, Carucci NM, Capsoni S, Cattaneo A, et al
    Amyloid Plaque-Independent Deficit of Early Postnatal Visual Cortical Plasticity in the 5XFAD Transgenic Model of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  714. CURE S, Abrams K, Belger M, Dell'agnello G, et al
    Systematic Literature Review and Meta-Analysis of Diagnostic Test Accuracy in Alzheimer's Disease and Other Dementia Using Autopsy as Standard of Truth.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  715. KUMFOR F, Hodges JR, Piguet O
    Ecological Assessment of Emotional Enhancement of Memory in Progressive Nonfluent Aphasia and Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  716. MOREIRA HS, Lima CF, Vicente SG
    Examining Executive Dysfunction with the Institute of Cognitive Neurology (INECO) Frontal Screening (IFS): Normative Values from a Healthy Sample and Clinical Utility in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  717. ASHFORD JW, Furst AJ
    Advancing Brain Imaging for Alzheimer's Disease: Integrating Anatomic and Physiologic Measures.
    J Alzheimers Dis. 2014.
    PubMed     Text format    


  718. YANG YH, Wang H, Lam L, Chan WC, et al
    Characteristics of Alzheimer's Disease among Patients in Taiwan, Hong Kong, and Beijing.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  719. O'DAY DH, Catalano A
    A Lack of Correlation between the Incidence of Lyme Disease and Deaths due to Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  720. ARAYA JA, Ramirez AE, Figueroa-Aroca D, Sotes GJ, et al
    Modulation of Neuronal Nicotinic Receptor by Quinolizidine Alkaloids Causes Neuroprotection on a Cellular Alzheimer Model.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  721. RUSANEN M, Kivipelto M, Levalahti E, Laatikainen T, et al
    Heart Diseases and Long-Term Risk of Dementia and Alzheimer's Disease: A Population-Based CAIDE Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  722. ALCOLEA D, Carmona-Iragui M, Suarez-Calvet M, Sanchez-Saudinos MB, et al
    Relationship Between beta-Secretase, Inflammation and Core Cerebrospinal Fluid Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  723. PUJOL-GIMENEZ J, Martisova E, Perez-Mediavilla A, Lostao MP, et al
    Expression of the Glucose Transporter GLUT12 in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  724. GOLDSMITH HS
    Benefit of Omental Blood Flow in Alzheimer's Disease: Effect on Deteriorating Neurons.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  725. KRAJCOVICOVA L, Mikl M, Marecek R, Rektorova I, et al
    Disturbed Default Mode Network Connectivity Patterns in Alzheimer's Disease Associated with Visual Processing.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


    April 2014
  726. MANAFIRAD A, Farzadfar F, Habibi L, Azhdarzadeh M, et al
    Is Amyloid-beta an Innocent Bystander and Marker in Alzheimer's Disease? Is the Liability of Multivalent Cation Homeostasis and its Influence on Amyloid-beta Function the Real Mechanism?
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  727. YANG M, Miao J, Rizak J, Zhai R, et al
    Alzheimer's Disease and Methanol Toxicity (Part 2): Lessons from Four Rhesus Macaques (Macaca mulatta) Chronically Fed Methanol.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  728. YANG M, Lu J, Miao J, Rizak J, et al
    Alzheimer's Disease and Methanol Toxicity (Part 1): Chronic Methanol Feeding Led to Memory Impairments and Tau Hyperphosphorylation in Mice.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  729. TAIPALE H, Koponen M, Tanskanen A, Tolppanen AM, et al
    Antipsychotic Polypharmacy among a Nationwide Sample of Community-Dwelling Persons with Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  730. WARAGAI M, Hata S, Suzuki T, Ishii R, et al
    Utility of SPM8 plus DARTEL (VSRAD) Combined with Magnetic Resonance Spectroscopy as Adjunct Techniques for Screening and Predicting Dementia due to Alzheimer's Disease in Clinical Practice.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  731. SZIGETI K, Kellermayer B, Lentini JM, Trummer B, et al
    Ordered Subset Analysis of Copy Number Variation Association with Age at Onset of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  732. ETHELL DW
    Disruption of Cerebrospinal Fluid Flow through the Olfactory System May Contribute to Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  733. SUN J, Song F, Wang J, Han G, et al
    Hidden Risk Genes with High-Order Intragenic Epistasis in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  734. HERNANDEZ-RODRIGUEZ M, Correa-Basurto J, Martinez-Ramos F, Padilla-Martinez II, et al
    Design of Multi-Target Compounds as AChE, BACE1, and Amyloid-beta1-42 Oligomerization Inhibitors: In Silico and In Vitro Studies.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  735. XIE J, Gabelle A, Dorey A, Garnier-Crussard A, et al
    Initial Memory Deficit Profiles in Patients with a Cerebrospinal Fluid Alzheimer's Disease Signature.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  736. MIYASHITA A, Wen Y, Kitamura N, Matsubara E, et al
    Lack of Genetic Association Between TREM2 and Late-Onset Alzheimer's Disease in a Japanese Population.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  737. BRANDNER S, Thaler C, Lelental N, Buchfelder M, et al
    Ventricular and Lumbar Cerebrospinal Fluid Concentrations of Alzheimer's Disease Biomarkers in Patients with Normal Pressure Hydrocephalus and Posttraumatic Hydrocephalus.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  738. MATTACE-RASO F
    Is Memantine + Acetylcholinesterase Inhibitor Treatment Superior to Either Therapy Alone in Alzheimer's Disease?
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  739. FALAHATI F, Westman E, Simmons A
    Multivariate Data Analysis and Machine Learning in Alzheimer's Disease with a Focus on Structural Magnetic Resonance Imaging.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  740. SAMAN S, Lee NC, Inoyo I, Jin J, et al
    Proteins Recruited to Exosomes by Tau Overexpression Implicate Novel Cellular Mechanisms Linking Tau Secretion with Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  741. TESTI S, Peluso S, Fabrizi GM, Antenora A, et al
    A Novel PSEN1 Mutation in a Patient with Sporadic Early-Onset Alzheimer's Disease and Prominent Cerebellar Ataxia.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  742. SANCHEZ-BENAVIDES G, Pena-Casanova J, Casals-Coll M, Gramunt N, et al
    Cognitive and Neuroimaging Profiles in Mild Cognitive Impairment and Alzheimer's Disease: Data from the Spanish Multicenter Normative Studies (NEURONORMA Project).
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  743. STRUYFS H, Molinuevo JL, Martin JJ, De Deyn PP, et al
    Validation of the AD-CSF-Index in Autopsy-Confirmed Alzheimer's Disease Patients and Healthy Controls.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


    March 2014
  744. VERMEIREN Y, Van Dam D, Aerts T, Engelborghs S, et al
    Brain Region-Specific Monoaminergic Correlates of Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  745. WILHELMUS MM, de Jager M, Bakker EN, Drukarch B, et al
    Tissue Transglutaminase in Alzheimer's Disease: Involvement in Pathogenesis and its Potential as a Therapeutic Target.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  746. SUN Q, Hampel H, Blennow K, Lista S, et al
    Increased Plasma TACE Activity in Subjects with Mild Cognitive Impairment and Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  747. SHIH YH, Tsai KJ, Lee CW, Shiesh SC, et al
    Apolipoprotein C-III is an Amyloid-beta-Binding Protein and an Early Marker for Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  748. CADENA-DEL-CASTILLO C, Valdes-Quezada C, Carmona-Aldana F, Arias C, et al
    Age-Dependent Increment of Hydroxymethylation in the Brain Cortex in the Triple-Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  749. ALEGRET M, Cuberas-Borros G, Espinosa A, Valero S, et al
    Cognitive, Genetic, and Brain Perfusion Factors Associated with Four Year Incidence of Alzheimer's Disease from Mild Cognitive Impairment.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  750. ZLATAR ZZ, Wierenga CE, Bangen KJ, Liu TT, et al
    Increased Hippocampal Blood Flow in Sedentary Older Adults at Genetic Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  751. LEE GJ, Lu PH, Mather MJ, Shapira J, et al
    Neuroanatomical Correlates of Emotional Blunting in Behavioral Variant Frontotemporal Dementia and Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  752. MARSHALL GA, Lorius N, Locascio JJ, Hyman BT, et al
    Regional Cortical Thinning and Cerebrospinal Biomarkers Predict Worsening Daily Functioning Across the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  753. ZADORI D, Veres G, Szalardy L, Klivenyi P, et al
    Glutamatergic Dysfunctioning in Alzheimer's Disease and Related Therapeutic Targets.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  754. KRISTOFIKOVA Z, Ricny J, Kolarova M, Vyhnalek M, et al
    Interactions between Amyloid-beta and Tau in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  755. MAK HK, Qian W, Ng KS, Chan Q, et al
    Combination of MRI Hippocampal Volumetry and Arterial Spin Labeling MR Perfusion at 3-Tesla Improves the Efficacy in Discriminating Alzheimer's Disease from Cognitively Normal Elderly Adults.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  756. RUSSELL CL, Koncarevic S, Ward MA
    Post-Translational Modifications in Alzheimer's Disease and the Potential for New Biomarkers.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  757. TAN CC, Yu JT, Wang HF, Tan MS, et al
    Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  758. FENG X, Bai Z, Wang J, Xie B, et al
    Robust Gene Dysregulation in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  759. LEYTON CE, Savage S, Irish M, Schubert S, et al
    Verbal Repetition in Primary Progressive Aphasia and Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  760. CHU J, Lauretti E, Craige CP, Pratico D, et al
    Pharmacological Modulation of GSAP Reduces Amyloid-beta Levels and Tau Phosphorylation in a Mouse Model of Alzheimer's Disease with Plaques and Tangles.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  761. SHAO H, Zhang Y, Dong Y, Yu B, et al
    Chronic Treatment with Anesthetic Propofol Improves Cognitive Function and Attenuates Caspase Activation in Both Aged and Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  762. GARERI P, Putignano D, Castagna A, Cotroneo AM, et al
    Retrospective Study on the Benefits of Combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: The MEMAGE Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  763. YU YZ, Wang WB, Chen A, Chang Q, et al
    Strikingly Reduced Amyloid Burden and Improved Behavioral Performance in Alzheimer's Disease Mice Immunized with Recombinant Chimeric Vaccines by Hexavalent Foldable Abeta1-15 Fused to Toxin-Derived Carrier Proteins.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  764. KHEMKA VK, Bagchi D, Bandyopadhyay K, Bir A, et al
    Altered Serum Levels of Adipokines and Insulin in Probable Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  765. TIWARI V, Patel AB
    Pyruvate Carboxylase and Pentose Phosphate Fluxes are Reduced in AbetaPP-PS1 Mouse Model of Alzheimer's Disease: A 13C NMR Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  766. NELSON L, Gard P, Tabet N
    Hypertension and Inflammation in Alzheimer's Disease: Close Partners in Disease Development and Progression!
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  767. ERIKSSON H, Fereshtehnejad SM, Falahati F, Farahmand B, et al
    Differences in Routine Clinical Practice between Early and Late Onset Alzheimer's Disease: Data from the Swedish Dementia Registry (SveDem).
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  768. OLDE RIKKERT MG, Verhey FR, Sijben JW, Bouwman FH, et al
    Differences in Nutritional Status between very Mild Alzheimer's Disease Patients and Healthy Controls.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  769. SAUVEE M, Didierlaurent G, Latarche C, Escanye MC, et al
    Additional Use of Abeta42/Abeta40 Ratio with Cerebrospinal Fluid Biomarkers P-Tau and Abeta42 Increases the Level of Evidence of Alzheimer's Disease Pathophysiological Process in Routine Practice.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  770. EVANGELISTI E, Zampagni M, Cascella R, Becatti M, et al
    Plasma Membrane Injury Depends on Bilayer Lipid Composition in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  771. ALONSO R, Pisa D, Marina AI, Morato E, et al
    Fungal Infection in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  772. TAJES M, Eraso-Pichot A, Rubio-Moscardo F, Guivernau B, et al
    Methylglyoxal Produced by Amyloid-beta Peptide-Induced Nitrotyrosination of Triosephosphate Isomerase Triggers Neuronal Death in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  773. KIM GH, Kim JE, Choi KG, Lim SM, et al
    T1-weighted Axial Visual Rating Scale for an Assessment of Medial Temporal Atrophy in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  774. HOOK G, Yu J, Toneff T, Kindy M, et al
    Brain Pyroglutamate Amyloid-Beta is Produced by Cathepsin B and is Reduced by the Cysteine Protease Inhibitor E64d, Representing a Potential Alzheimer's Disease Therapeutic.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  775. LODEIRO M, Ibanez C, Cifuentes A, Simo C, et al
    Decreased Cerebrospinal Fluid Levels of L-Carnitine in Non-Apolipoprotein E4 Carriers at Early Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


    February 2014
  776. KAPILA AK, Watts HR, Wang T, Ma D, et al
    The Impact of Surgery and Anesthesia on Post-Operative Cognitive Decline and Alzheimer's Disease Development: Biomarkers and Preventive Strategies.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  777. SONG G, Zhang Z, Wen L, Chen C, et al
    Selenomethionine Ameliorates Cognitive Decline, Reduces Tau Hyperphosphorylation, and Reverses Synaptic Deficit in the Triple Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  778. SILVERSTEIN JH
    Influence of Anesthetics on Alzheimer's Disease: Biophysical, Animal Model, and Clinical Reports.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  779. TEIPEL SJ, Grothe MJ, Filippi M, Fellgiebel A, et al
    Fractional Anisotropy Changes in Alzheimer's Disease Depend on the Underlying Fiber Tract Architecture: A Multiparametric DTI Study using Joint Independent Component Analysis.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  780. WALTON JR
    Chronic Aluminum Intake Causes Alzheimer's Disease: Applying Sir Austin Bradford Hill's Causality Criteria.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  781. GHARBIYA M, Trebbastoni A, Parisi F, Manganiello S, et al
    Choroidal Thinning as a New Finding in Alzheimer's Disease: Evidence from Enhanced Depth Imaging Spectral Domain Optical Coherence Tomography.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  782. DE OLIVEIRA FF, Bertolucci PH, Chen ES, Smith MC, et al
    Brain-Penetrating Angiotensin-Converting Enzyme Inhibitors and Cognitive Change in Patients with Dementia due to Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  783. HALL JR, Wiechmann AR, Johnson LA, Edwards M, et al
    The Impact of APOE Status on Relationship of Biomarkers of Vascular Risk and Systemic Inflammation to Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  784. BRACCO L, Bessi V, Padiglioni S, Marini S, et al
    Do Cholinesterase Inhibitors Act Primarily on Attention Deficit? A Naturalistic Study in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  785. TAN L, Yu JT, Tan MS, Liu QY, et al
    Genome-Wide Serum microRNA Expression Profiling Identifies Serum Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  786. CAVEDO E, Redolfi A, Angeloni F, Babiloni C, et al
    The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): Validation of Structural MR Imaging.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  787. HANZEL CE, Iulita MF, Eyjolfsdottir H, Hjorth E, et al
    Analysis of Matrix Metallo-Proteases and the Plasminogen System in Mild Cognitive Impairment and Alzheimer's Disease Cerebrospinal Fluid.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  788. WALTERFANG M, Luders E, Looi JC, Rajagopalan P, et al
    Shape Analysis of the Corpus Callosum in Alzheimer's Disease and Frontotemporal Lobar Degeneration Subtypes.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  789. ZHONG X, Shi H, Shen Z, Hou L, et al
    1H-Proton Magnetic Resonance Spectroscopy Differentiates Dementia with Lewy Bodies from Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  790. ZHANG Q, Descamps O, Hart MJ, Poksay K, et al
    Paradoxical Effect of TrkA Inhibition in Alzheimer's Disease Models.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  791. RAMOS-FERNANDEZ E, Tajes M, Palomer E, Ill-Raga G, et al
    Posttranslational Nitro-Glycative Modifications of Albumin in Alzheimer's Disease: Implications in Cytotoxicity and Amyloid-beta Peptide Aggregation.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  792. KILIMANN I, Grothe M, Heinsen H, Alho EJ, et al
    Subregional Basal Forebrain Atrophy in Alzheimer's Disease: A Multicenter Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  793. GRAMMAS P, Martinez J, Sanchez A, Yin X, et al
    A New Paradigm for the Treatment of Alzheimer's Disease: Targeting Vascular Activation.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  794. YANG H, Lyutvinskiy Y, Herukka SK, Soininen H, et al
    Prognostic Polypeptide Blood Plasma Biomarkers of Alzheimer's Disease Progression.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  795. SAHARAN S, Mandal PK
    The Emerging Role of Glutathione in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  796. BEDSE G, Romano A, Cianci S, Lavecchia AM, et al
    Altered Expression of the CB1 Cannabinoid Receptor in the Triple Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  797. CUNNINGHAM RL, Singh M, O'Bryant SE, Hall JR, et al
    Oxidative Stress, Testosterone, and Cognition among Caucasian and Mexican-American Men with and without Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  798. O'CAOIMH R, Healy L, Gao Y, Svendrovski A, et al
    Effects of Centrally acting Angiotensin Converting Enzyme Inhibitors on Functional Decline in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  799. SUI X, Ren X, Huang P, Li S, et al
    Proteomic Analysis of Serum Proteins in Triple Transgenic Alzheimer's Disease Mice: Implications for Identifying Biomarkers for Use to Screen Potential Candidate Therapeutic Drugs for Early Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


    January 2014

  800. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2014;39:703-5.
    PubMed     Text format    



  801. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2014;40:229-32.
    PubMed     Text format    



  802. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2014;40:477-9.
    PubMed     Text format    



  803. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2014;40:759-61.
    PubMed     Text format    



  804. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2014;40:1065-7.
    PubMed     Text format    



  805. Nepriysin-Like Acticity Correlates with CSF-Tau and Phospho-Tau in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2014;40:1063.
    PubMed     Text format    



  806. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2014;41:329-30.
    PubMed     Text format    


  807. KORAN ME, Hohman TJ, Meda SA, Thornton-Wells TA, et al
    Genetic interactions within inositol-related pathways are associated with longitudinal changes in ventricle size.
    J Alzheimers Dis. 2014;38:145-54.
    PubMed     Text format     Abstract available


  808. CUMMINGS J, Zhong K, Bernick C
    The Cleveland Clinic Lou Ruvo Center for Brain Health: keeping memory alive.
    J Alzheimers Dis. 2014;38:103-9.
    PubMed     Text format     Abstract available


  809. CHIEN DT, Szardenings AK, Bahri S, Walsh JC, et al
    Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.
    J Alzheimers Dis. 2014;38:171-84.
    PubMed     Text format     Abstract available


  810. CANO-CUENCA N, Solis-Garcia del Pozo JE, Jordan J
    Evidence for the efficacy of latrepirdine (Dimebon) treatment for improvement of cognitive function: a meta-analysis.
    J Alzheimers Dis. 2014;38:155-64.
    PubMed     Text format     Abstract available



  811. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2014;41:651-3.
    PubMed     Text format    


  812. WANG J, Varghese M, Ono K, Yamada M, et al
    Cocoa Extracts Reduce Oligomerization of Amyloid-beta: Implications for Cognitive Improvement in Alzheimer's Disease.
    J Alzheimers Dis. 2014;41:643-50.
    PubMed     Text format     Abstract available


  813. NARME P, Clement S, Ehrle N, Schiaratura L, et al
    Efficacy of musical interventions in dementia: evidence from a randomized controlled trial.
    J Alzheimers Dis. 2014;38:359-69.
    PubMed     Text format     Abstract available


  814. KAMMINGA J, O'Callaghan C, Hodges JR, Irish M, et al
    Differential prospective memory profiles in frontotemporal dementia syndromes.
    J Alzheimers Dis. 2014;38:669-79.
    PubMed     Text format     Abstract available


  815. GALLUCCI M, Zanardo A, Bendini M, Di Paola F, et al
    Serum folate, homocysteine, brain atrophy, and auto-CM system: The Treviso Dementia (TREDEM) study.
    J Alzheimers Dis. 2014;38:581-7.
    PubMed     Text format     Abstract available



  816. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2014;41:959-60.
    PubMed     Text format    



  817. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2014;41:1261-2.
    PubMed     Text format    



  818. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2014;42:345-6.
    PubMed     Text format    


  819. TZANOULINOU S, Brandi R, Arisi I, D'Onofrio M, et al
    Pathogen-free husbandry conditions alleviate behavioral deficits and neurodegeneration in AD10 anti-NGF mice.
    J Alzheimers Dis. 2014;38:951-64.
    PubMed     Text format     Abstract available


  820. MILOJEVIC J, Costa M, Ortiz AM, Jorquera JI, et al
    In vitro amyloid-beta binding and inhibition of amyloid-beta self-association by therapeutic albumin.
    J Alzheimers Dis. 2014;38:753-65.
    PubMed     Text format     Abstract available



  821. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2014;42:705-6.
    PubMed     Text format    


  822. TIMMER NM, Metaxas A, van der Stelt I, Kluijtmans LA, et al
    Cerebral level of vGlut1 is increased and level of glycine is decreased in TgSwDI mice.
    J Alzheimers Dis. 2014;39:89-101.
    PubMed     Text format     Abstract available


  823. DOLZHANSKAYA N, Gonzalez MA, Sperziani F, Stefl S, et al
    A novel p.Leu(381)Phe mutation in presenilin 1 is associated with very early onset and unusually fast progressing dementia as well as lysosomal inclusions typically seen in Kufs disease.
    J Alzheimers Dis. 2014;39:23-7.
    PubMed     Text format     Abstract available


  824. RUNTTI H, Mattila J, van Gils M, Koikkalainen J, et al
    Quantitative evaluation of disease progression in a longitudinal mild cognitive impairment cohort.
    J Alzheimers Dis. 2014;39:49-61.
    PubMed     Text format     Abstract available


  825. GALIMBERTI D, Arosio B, Fenoglio C, Serpente M, et al
    Incomplete penetrance of the C9ORF72 hexanucleotide repeat expansions: frequency in a cohort of geriatric non-demented subjects.
    J Alzheimers Dis. 2014;39:19-22.
    PubMed     Text format     Abstract available


  826. XU H, Lu B, Zheng B, Tian J, et al
    Smaller sized inhaled anesthetics have more potency on senescence-accelerated prone-8 mice compared with senescence-resistant-1 mice.
    J Alzheimers Dis. 2014;39:29-34.
    PubMed     Text format     Abstract available



  827. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2014;42:1047-9.
    PubMed     Text format    


  828. YANAGISAWA D, Taguchi H, Ibrahim NF, Morikawa S, et al
    Preferred features of a fluorine-19 MRI probe for amyloid detection in the brain.
    J Alzheimers Dis. 2014;39:617-31.
    PubMed     Text format     Abstract available



  829. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2014;42:1487-8.
    PubMed     Text format    


  830. SOLFRIZZI V, Panza F
    Mediterranean diet and cognitive decline. A lesson from the whole-diet approach: what challenges lie ahead?
    J Alzheimers Dis. 2014;39:283-6.
    PubMed     Text format     Abstract available


  831. PEREZ-GARMENDIA R, Hernandez-Zimbron LF, Morales MA, Luna-Munoz J, et al
    Identification of N-terminally truncated pyroglutamate amyloid-beta in cholesterol-enriched diet-fed rabbit and AD brain.
    J Alzheimers Dis. 2014;39:441-55.
    PubMed     Text format     Abstract available


  832. XIAN YF, Mao QQ, Wu JC, Su ZR, et al
    Isorhynchophylline treatment improves the amyloid-beta-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    J Alzheimers Dis. 2014;39:331-46.
    PubMed     Text format     Abstract available


  833. RODRIGUEZ-GOMEZ O, Palacio-Lacambra ME, Palasi A, Ruiz-Laza A, et al
    Prevention of Alzheimer's disease: a global challenge for next generation neuroscientists.
    J Alzheimers Dis. 2014;42:S515-23.
    PubMed     Text format     Abstract available


  834. CHEUNG CY, Ong YT, Ikram MK, Chen C, et al
    Retinal microvasculature in Alzheimer's disease.
    J Alzheimers Dis. 2014;42:S339-52.
    PubMed     Text format     Abstract available


  835. MINERS JS, Jones R, Love S
    Differential changes in Abeta42 and Abeta40 with age.
    J Alzheimers Dis. 2014;40:727-35.
    PubMed     Text format     Abstract available


  836. QIANG M, Xiao R, Su T, Wu BB, et al
    A novel mechanism for endogenous formaldehyde elevation in SAMP8 mouse.
    J Alzheimers Dis. 2014;40:1039-53.
    PubMed     Text format     Abstract available


  837. TROUSSIERE AC, Wallon D, Mouton-Liger F, Yatimi R, et al
    Who needs cerebrospinal biomarkers? A national survey in clinical practice.
    J Alzheimers Dis. 2014;40:857-61.
    PubMed     Text format     Abstract available


  838. BRINKLEY WR, Perry G
    Lester (Skip) Binder (1949-2013): in the beginning was tau.
    J Alzheimers Dis. 2014;40 Suppl 1:S5.
    PubMed     Text format    


  839. MEDINA M, Avila J
    Is tau a prion-like protein?
    J Alzheimers Dis. 2014;40 Suppl 1:S1-3.
    PubMed     Text format    


  840. ANDO K, Kabova A, Stygelbout V, Leroy K, et al
    Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
    J Alzheimers Dis. 2014;40 Suppl 1:S135-45.
    PubMed     Text format     Abstract available


  841. CONGDON EE, Krishnaswamy S, Sigurdsson EM
    Harnessing the immune system for treatment and detection of tau pathology.
    J Alzheimers Dis. 2014;40 Suppl 1:S113-21.
    PubMed     Text format     Abstract available


  842. ROSEN AC, Ashford JW, Perry G
    Ethics review as a catalyst for progress.
    J Alzheimers Dis. 2014;40:233-5.
    PubMed     Text format     Abstract available


  843. SAYAS CL, Avila J
    Crosstalk between axonal classical microtubule-associated proteins and end binding proteins during axon extension: possible implications in neurodegeneration.
    J Alzheimers Dis. 2014;40 Suppl 1:S17-22.
    PubMed     Text format     Abstract available


  844. AVILA J, Simon D, Diaz-Hernandez M, Pintor J, et al
    Sources of extracellular tau and its signaling.
    J Alzheimers Dis. 2014;40 Suppl 1:S7-S15.
    PubMed     Text format     Abstract available


  845. SCHMAND B, Rienstra A, Tamminga H, Richard E, et al
    Responsiveness of magnetic resonance imaging and neuropsychological assessment in memory clinic patients.
    J Alzheimers Dis. 2014;40:409-18.
    PubMed     Text format     Abstract available


  846. VAN DER FLIER WM, Pijnenburg YA, Prins N, Lemstra AW, et al
    Optimizing patient care and research: the Amsterdam Dementia Cohort.
    J Alzheimers Dis. 2014;41:313-27.
    PubMed     Text format     Abstract available


  847. HARRIS CJ, Voss K, Murchison C, Ralle M, et al
    Oral zinc reduces amyloid burden in Tg2576 mice.
    J Alzheimers Dis. 2014;41:179-92.
    PubMed     Text format     Abstract available


  848. MOON M, Cha MY, Mook-Jung I
    Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
    J Alzheimers Dis. 2014;41:233-41.
    PubMed     Text format     Abstract available


  849. VECCHIO F, Miraglia F, Marra C, Quaranta D, et al
    Human brain networks in cognitive decline: a graph theoretical analysis of cortical connectivity from EEG data.
    J Alzheimers Dis. 2014;41:113-27.
    PubMed     Text format     Abstract available


  850. FITZ NF, Castranio EL, Carter AY, Kodali R, et al
    Improvement of memory deficits and amyloid-beta clearance in aged APP23 mice treated with a combination of anti-amyloid-beta antibody and LXR agonist.
    J Alzheimers Dis. 2014;41:535-49.
    PubMed     Text format     Abstract available


  851. COSKUNER O, Murray IV
    Adenosine triphosphate (ATP) reduces amyloid-beta protein misfolding in vitro.
    J Alzheimers Dis. 2014;41:561-74.
    PubMed     Text format     Abstract available


  852. KORECKA M, Waligorska T, Figurski M, Toledo JB, et al
    Qualification of a surrogate matrix-based absolute quantification method for amyloid-beta(4)(2) in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry.
    J Alzheimers Dis. 2014;41:441-51.
    PubMed     Text format     Abstract available


  853. MIGNARDOT JB, Beauchet O, Annweiler C, Cornu C, et al
    Postural sway, falls, and cognitive status: a cross-sectional study among older adults.
    J Alzheimers Dis. 2014;41:431-9.
    PubMed     Text format     Abstract available


  854. RAMI L, Mollica MA, Garcia-Sanchez C, Saldana J, et al
    The Subjective Cognitive Decline Questionnaire (SCD-Q): a validation study.
    J Alzheimers Dis. 2014;41:453-66.
    PubMed     Text format     Abstract available


  855. FROESTL W, Muhs A, Pfeifer A
    Cognitive enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014.
    J Alzheimers Dis. 2014;41:961-1019.
    PubMed     Text format     Abstract available


  856. FU Y, Rusznak Z, Kwok JB, Kim WS, et al
    Age-dependent alterations of the hippocampal cell composition and proliferative potential in the hAbetaPPSwInd-J20 mouse.
    J Alzheimers Dis. 2014;41:1177-92.
    PubMed     Text format     Abstract available


  857. VANGAVARAGU JR, Valasani KR, Fang D, Williams TD, et al
    Determination of small molecule ABAD inhibitors crossing blood-brain barrier and pharmacokinetics.
    J Alzheimers Dis. 2014;42:333-44.
    PubMed     Text format     Abstract available


  858. DE BRUIJN RF, Janssen JA, Brugts MP, van Duijn CM, et al
    Insulin-like growth factor-I receptor stimulating activity is associated with dementia.
    J Alzheimers Dis. 2014;42:137-42.
    PubMed     Text format     Abstract available


    January 2013

  859. 2013 Alzheimer Award.
    J Alzheimers Dis. 2013;36:413-4.
    PubMed     Text format    


  860. PETERS OM, Shelkovnikova T, Tarasova T, Springe S, et al
    Chronic administration of Dimebon does not ameliorate amyloid-beta pathology in 5xFAD transgenic mice.
    J Alzheimers Dis. 2013;36:589-96.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: